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ABSTRACT 
 
The geographic disparity of multiple sclerosis has been noted in the literature for well 
over a century.  The frequency of the disease varies significantly both within countries 
and in different parts of the world.  The goal of this project is to give new insight 
regarding the etiology of multiple sclerosis.  Several theories regarding the etiology of the 
disease have been reviewed, including a geographic theory, a nutritional theory, and a 
genetic theory.  Although the geographic and nutritional theories have been thoroughly 
investigated by researchers, neither of them provides a conclusive explanation for the 
etiology of the disease, and there are discrepancies with respect to both theories.  The 
purpose of this study is to reveal the discrepancies in the epigenetic theories regarding the 
etiology of multiple sclerosis and to demonstrate the correlation of multiple sclerosis 
prevalence and the migration and settlement history of Northern Europeans, thus 
conferring the passage of a genetic susceptibility to the disease. 
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CHAPTER I   
INTRODUCTION 
 
Multiple sclerosis is a chronic inflammatory disease that affects the central 
nervous system (CNS).  In patients with multiple sclerosis, myelin, the fatty tissue which 
protects nerve fibers in the CNS, deteriorates leading to neurological problems and 
disorders of the CNS.  Patients with multiple sclerosis suffer from a variety of symptoms, 
including visual problems, muscle weakness, difficulties with coordination and speech, 
fatigue, cognitive impairment, problems with balance, and pain.  Multiple sclerosis is a 
debilitating disease which leads to impaired mobility and disability in most cases.   
Currently, there are approximately 400,000 patients suffering from multiple 
sclerosis in North America, and approximately 1.1 million people suffer from the disease 
worldwide.  The average age of onset is between 20 and 30 years.  The disease rarely 
occurs prior to age 10 or after 60 years of age.  However, patients as young as 3 and as 
old as 67 years of age have been diagnosed with the disease.  Females are diagnosed 1.4 
to 3.1 times more frequently than males (National Multiple Sclerosis Society 2007). 
 It appears that multiple sclerosis is a modern day disease, but there has been 
mention of symptoms associated with the disease as far back as the 14th century.  In 1947, 
the skeleton of St. Lidwina of Schiedam, which is a suburb of Rotterdam, Holland, was 
discovered during a reconstruction project.  It appeared that Lidwina, who lived from 
1380 to 1433 had a case of MS.  The skeleton showed signs of muscular atrophy and 
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paralysis of both legs.  It was recorded that Lidwina suffered from difficulty walking and 
a “hanging lip” which could possibly be indicative of facial paralysis.  It was also 
recorded that in the last 15 years of her life, Lidwina had large wounds on her body, 
difficulty swallowing, blindness, and other pains (Murray 2005).   
 In 1979, Flemish neurologist Medaer analyzed Lidwina’s case and stated that it is 
likely she suffered from MS, although MS is not the only explanation for her symptoms.  
Other physicians have analyzed the case and believe that Lidwina’s case could also be 
attributable to Lupus Erythematosus, which is another autoimmune disease associated 
with skin lesions and disorders of CNS, including blindness. Although Lidwina’s case 
cannot conclusively be described as MS, there are some other cases throughout history 
that have also been ascribed as MS.  It is interesting to note that all of the cases 
mentioned herein have been located in northern Europe, where it is believed the disease 
originated (Murray 2005 and Swiderski 1998). 
The case of Sir Augustus Frederic D’Este, son of King George III of England, has 
also been described as a likely case of MS. As a child he suffered from common 
childhood infections and infestations. In 1827, D’Este exhibited the first serious health 
malady indicative of MS.  Then, at age 33, D’Este stated that he was experiencing 
difficulty with vision, and he later experienced numbness of the lower back and thighs, 
difficulties walking and incontinence.  D’Este died at the age of 35, and at the age of his 
death, he was losing his sense of hearing and was experiencing spasms so severe that he 
could only walk with the help of a servant (Murray 2005 and Swiderski 1998). 
Robert Carswell was a Scottish medical student in the 1830s.  Carswell was a 
medical artist who created a collection of drawings for his “Pathological Anatomy: 
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Illustrations of the Elementary Forms of Disease” (1834-1838). Within the collection of 
drawings, Carswell described lesions typical of MS based on two cases from Hospital of 
La Pitie and the Hospital of La Charite. Both patients suffered from paralysis.  
Furthermore, Jean Cruveilhier, a Parisian artist of the same time period as Carswell 
created another collection of pathological illustrations which were published in 
“Anatomie pathologique”.  Along with his drawings, Cruveilhier provided a case history 
and detailed clinical notes of patients including La Charite, Josephine Paget.  The patient 
died at the age of 38 on March 20, 1840.  Cruveilhier performed an autopsy and 
described what were likely to be MS lesions as “sclerose en plaques” (Swiderski 1998). 
A French neurologist and student of Jean Cruveilhier, Jean-Martin Charcot, 
established the infamous Charcot Clinic at the Salpêtrière Hospital for investigating 
mental and neurological disorders.  In 1862, Charcot and Edme Vulpian wrote a literature 
review on “sclerose en plaques” citing mostly German sources. Charcot studied multiple 
sclerosis intensely and gave lectures on the disease, which he continued to describe as 
“sclerose en plaque” between 1868 and 1871.  In 1892, Charcot published the most 
comprehensive account of MS and it included accounts of mainly patients of northern 
European descent (Swiderski 1998).   
Multiple sclerosis is characterized by its epidemiological disparity in that it is 
most frequently diagnosed in northern European nations and is rarely documented in non-
Caucasian races.  There are multiple theories on the etiology of multiple sclerosis, 
including geographic, cultural and behavioral, and genetic suppositions, but to date, none 
of these theories has been able to conclusively identify the etiology of the disease.  
Approximately 15 to 20% of affected individuals have a family history of the disease; 
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however, population studies have shown that there is no clear mode of inheritance of the 
disease (Compston and Coles 2002, Sadovnick 1988).  Thus, the etiology of multiple 
sclerosis remains unknown.  Studies have consistently shown that familial clustering 
results from shared genetic factors rather than epigenetic factors, leading to the idea that 
development of multiple sclerosis is primarily due to genetic predisposition.   
The geographic disparity of multiple sclerosis has been noted in the literature for 
well over a century (Charcot 1877).  Although the prevalence can be difficult to reliably 
assess from one geographical region to another (Poser 1994), it has become clear that the 
frequency of the disease varies significantly both within countries and in different parts 
of the world.  The first epidemiological study by Davenport (1922) revealed how multiple 
sclerosis seemed to affect individuals of Scandinavian and Finnish descent more than 
individuals in other ethnic groups.  Later, propositions that multiple sclerosis prevalence 
was related to global latitude sparked a nature versus nurture controversy that still exists 
today (Annegers 1991 and Betemps 1993). 
When visually documented on a world map, the prevalence of multiple sclerosis 
demonstrates striking features, such as the fact that according to lack of data from Africa 
and physicians’ claims, the disease is almost non-existent in African nations and other 
regions close to the equator, and the prevalence is much greater in nations of European 
descent.  For the purposes of this research project, Caucasian will be defined as white 
individuals of northern European descent, and African Americans can be categorized as 
black individuals whose ancestors originated in Africa but are currently living in America.  
Furthermore, Asian Americans will be defined as people currently living in America 
whose ancestors originated in Asia, including China, Japan, Taiwan, India, and Vietnam.  
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Interestingly, the occurrence of multiple sclerosis is lower in African Americans and 
Asian Americans than it is in Caucasian Americans, and it has been shown that there is a 
higher percentage of African and Asian descendents who have developed multiple 
sclerosis than the percentage of native Africans and Asians who have developed the 
disease (Alter 1962, Oh 1969, and Rosati 2001).  Thus, I hypothesize that since multiple 
sclerosis occurs frequently in certain racial groups in certain geographic areas, a 
comparison of global multiple sclerosis prevalence rates among nations and among racial 
groups within the nations would help to determine whether the disease coincides with the 
migration, settlement history, and admixture of the Scandinavians, who may carry a 
susceptibility allele to the disease.  Furthermore, it is through genetic admixture from the 
Europeans to Africans throughout history, and specifically during the Slave Trade, that 
the genetic susceptibility to multiple sclerosis has been passed to the African genome.   
Remarkably, similar studies have been conducted to link susceptibility to cystic 
fibrosis, hemochromatosis, and prostate cancer with the migration of northern Europeans.  
It has been found that the genetic epidemiology of cystic fibrosis, hemochromatosis, and 
prostate cancer has shown that inter-group breeding may lead to spreading of the 
susceptibility alleles to other racial and ethnic groups (Sandblom et al. 2003, Higgins et al. 
2005, Gilbert et al. 1995, and Acton et al. 2001).  It appears then that the geographic 
distribution of the varied frequencies of a disease reflects the history of migration, 
settlement, and admixture of the population carrying the susceptibility, and that it is 
possible for a genetic susceptibility to have been passed from one group to another over 
several generations.  Genetic epidemiology has been used in tracing the history of cystic 
fibrosis, hemochromatosis, and prostate cancer to show that these diseases originated in 
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northern Europe and have been passed to other races and ethnicities through genetic 
admixture following inter-group breeding (Sandblom et al. 2003, Higgins et al. 2005, 
Gilbert et al. 1995, and Acton et al. 2001).   
A genetics-based etiology of multiple sclerosis is challenged by several seemingly 
contradicting facts.  First, the apparently random occurrence of multiple sclerosis in a 
population may be due to low penetrance of the etiologic alleles.  However, the 
distribution within populations could also be explained by epigenetic mechanisms or by 
gene-environment interaction.  Second, although African Americans, or individuals who 
have migrated to the United States from continental Africa, are susceptible to multiple 
sclerosis, generally, there is a much lower prevalence of the disease in their nations of 
origin in Africa, seemingly making it impossible for African Americans to have inherited 
the susceptibility from their African ancestors.  Third, multiple sclerosis incidence has 
been continuously rising in recent years in nations that once exhibited extremely low 
incidence, and there currently seems to be a surge in incidence.  Given that the cause of 
the trend is not clear, socioeconomic, dietary, and behavioral changes have been 
pondered as contributing factors.  Each of these concepts favor an epigenetic, rather than 
a genetic etiology for multiple sclerosis. 
 Several epigenetic theories exist regarding the etiology of multiple sclerosis.  The 
primary epigenetic theories, or theories that do not imply that genetic inheritance is the 
determining factor for developing multiple sclerosis, include a geographic theory and a 
nutritional theory.  The geographic theory entails that geographic location with respect to 
proximity to the equator largely determines incidence of multiple sclerosis, while the 
nutritional theory indicates that diet and vitamin D intake influence development of the 
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disease.  These epigenetic hypotheses for the etiology of multiple sclerosis have been 
studied at length, yet neither of these theories can fully explain the etiology of the disease. 
 It is of utmost importance to determine the etiology of this debilitating disease, 
especially for African Americans, who have proven to suffer from higher incidence of 
cerebellar dysfunction and more rapid accumulation of disabilities due to the progression 
of the disease (Marrie et al. 2006).  Identification of genetic susceptibility to the disease 
could lead to the establishment of a genomic marker for prediction and prevention of 
multiple sclerosis, which would, in turn, be beneficial to public health.  The purpose of 
this study is to reveal the discrepancies in the epigenetic theories regarding the etiology 
of multiple sclerosis and to demonstrate the association of multiple sclerosis prevalence 
rates with the migration and settlement history of Northern Europeans, thus conferring 
the passage of a genetic susceptibility to the disease. 
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CHAPTER II 
REVIEW OF THE LITERATURE 
 
There is an evident worldwide geographic distribution of multiple sclerosis which 
can be observed when the occurrence of the disease is plotted on a world map.   It 
appears that the highest prevalence of the disease is found in the northernmost latitudes of 
the northern hemisphere and the southernmost latitudes of the southern hemisphere 
(Kurtzke 1977).  This observation is based on the prevalence of the disease in 
Scandinavia, the northern United States and Canada, as well as Australia and New 
Zealand (Kurtzke 1977).  There are currently several theories describing the 
epidemiology of multiple sclerosis, including a nutritional theory, a geographic theory, 
and a genetic theory, all of which are analyzed herein.  Following the review of literature, 
Table 1 identifies some of the key literature reviewed in this research.   
 
Geography and nutrition in relation to development of multiple sclerosis 
 Epidemiological data indicates quite clearly that multiple sclerosis is a 
geographically-related disease.  The highest frequency of multiple sclerosis in the world 
is exhibited in Europe between 65 degrees and 45 degrees north latitude, the northern 
United States and southern Canada, and between 35 and 40 degrees south latitude in New 
Zealand, and southern Australia (Figure 1).   
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 According to Kurtzke (1977), these regions are surrounded by regions exhibiting medium 
prevalence rates of multiple sclerosis in Europe to the north, east, and south; in the 
southern United States; and in the northern and inland Australia.  Latin America, Asia 
and Africa exhibit fairly low prevalence of the disease.  Kurtzke noted early on that 
latitude is not a sufficient criterion for determining multiple sclerosis risk considering that 
at 40 degrees north latitude, multiple sclerosis is high in America, medium in Europe, and 
low in Asia.  Kurtzke (1977) did, however, note that high and medium risk areas 
appeared only in Europe or European colonies.  Within the United States, multiple 
sclerosis appears to be more common in Caucasians of northern European descent than in 
African Americans, Asian Americans, and Native Americans.  
 
Figure 1.  Nationwide prevalence rates in northern Europe, the U.S., Canada, and 
Australia and New Zealand, along with detailed latitudinal proximity to the equator 
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One of the hallmarks of multiple sclerosis remains its unequal distribution across 
the globe.  As previously noted, it is most common in populations of northern European 
descent, and is diagnosed most often in Scandinavian nations, the United Kingdom, and 
the northern United States and southern Canada (Compston 1997).  Regions of high 
incidence have been found in northwestern Sardinia (Sotgiu 2002 and Marrosu 2002) and 
Sicily (Grimaldi 2001 and Nicoletti 2005).  Several areas of abnormally high incidence of 
multiple sclerosis have been found in Finland, as well.  In these regions, there is an 
approximately two-fold increased prevalence than the national average.  Seinajoki in 
southern Ostrobothnia, Finland, recently demonstrated an incidence of 12 cases per 
10,000 people, which is the highest rate of multiple sclerosis reported anywhere in the 
world (Sumelahti 2001). 
Data from migration studies show that if the exposure to a higher risk 
environment occurs during adolescence (before 15 years of age,) the migrant assumes the 
higher risk of the environment. This concept is nicely illustrated in studies of native-born 
South African Caucasian population with low incidence of the disease versus high 
incidence of multiple sclerosis among Caucasian immigrants from Great Britain, where 
the disease is much more prevalent (Kurtzke 1977).  Epidemics of multiple sclerosis have 
been reported and these provide further evidence of importance of environmental factors 
in multiple sclerosis. The most notable “epidemic” was described on the Faroe Islands 
after they were occupied by British troops in W.W.II. Similar increases in incidence of 
the disease were seen on Shetland and Orkney Islands, in Iceland, and in Sardinia. A 
specific point agent for these epidemics was never identified (Kurtzke 1977).  
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Rosati et al. (1996) conducted a study in northern Sardinia, an island off the coast 
of Italy, to investigate the incidence of multiple sclerosis in the Sardinian province of 
Sassari.  Results of previous studies in the area had indicated that multiple sclerosis 
prevalence had increased more than two or three times than that of the standard increase 
in prevalence in continental Italy during the time between 1980 and 1996.  The purpose 
of this study was to investigate the temporal trend of multiple sclerosis prevalence, which 
is that as distance from the equator increases, so does prevalence of the disease.  Rosati et 
al. (1996) focused on the province of Sassari, which is located between latitudes 40º30’ N 
and 41º N.  The population of Sassari consists mostly of natives of Sardinia, and the 
count of foreign inhabitants with regards to the study was negligible.  Thus, the 
researchers concluded that generalizations regarding the study population and the island 
of Sardinia were warranted.  The differences between human genomes in Italy and 
Europe and Sardinia are 10 times higher than between non-Sardinian Italians and 
Europeans, yielding a genetically homogenous population (Pugliatti 2001).   
 The crude overall prevalence rate in Sassari in 1997 was 144.4 per 100,000.  
There were 686 total cases of multiple sclerosis, 492 women and 194 men.  The 
incidence rate was studied for the period between January 1, 1968 and December 31, 
1997.  The average annual incidence was found to be 4.9 per 100,000.  The total 
incidence rate had increased since the period of 1968-1972 from 2.0 per 100,000 to 6.8 
per 100,000 from 1993-1997 population (Pugliatti 2001).  Researchers concluded that the 
observed multiple sclerosis prevalence rates were markedly higher than expected rates 
would be in relation to the latitude of Sardinia.  An increase in disease rate due to 
increase in life expectancy was ruled out, as was an increase in immigration of people in 
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high-risk age groups, and immigration of genetically high-risk individuals.  Furthermore, 
comparison to survey data collected by Granieri et al. (1996) from Ferrara, a province in 
northern Italy revealed that prevalence of multiple sclerosis in Sassari was nearly three 
times higher and that better diagnostic accuracy and improved epidemiological methods 
could not fully account for the increased prevalence rates (Pugliatti 2001).  Results from 
this study indicated that the prevalence of multiple sclerosis in Sassari is among the 
highest in the world (Kurtzke 1997).  The high rate of multiple sclerosis in Sassari seems 
to contradict the latitude gradient-based theory of multiple sclerosis, which suggests that 
prevalence of multiple sclerosis is directly related to geographical latitudes, since 
multiple sclerosis rates increased considerably in Sassari over the 30 year period of the 
noted investigation, while they remained substantially unchanged in the similar 
latitudinal region of Ferrara (Pugliatti 2001 and Granieri 1996).  Instead, this research 
indicates that multiple sclerosis is more prevalent in genetically susceptible populations.   
 Research also suggests that nutrition and diet, particularly those high in 
consumption of animal fat and with low intake of fish products, may play a role in the 
etiology of multiple sclerosis.  Furthermore, it has also been suggested that vitamin D 
intake has a protective effect on the risk of multiple sclerosis (Munger et al. 2000).   
The theory regarding the protective effect of vitamin D intake on risk of 
developing multiple sclerosis is directly related to the geographic theory of the disease, 
which is that as distance from the equator decreases, so does prevalence of multiple 
sclerosis.  Exposure to sunlight, which increases as the distance from the equator 
decreases, results in greater intake of vitamin D (Goldberg 1974, Acheson 1960, 
Sutherland 1962, and Lebowitz 1967), and during the winter, high latitudinal regions 
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experience low levels of ultraviolet (UV) sunlight, thus producing inadequate amounts of 
vitamin D in individuals at latitudes greater than or equal to 42º (Webb 1988 and 
Ladizesky 1995).   
It has been shown that vitamin D dietary supplements given to mice have 
prevented development of experimental autoimmune encephalomyelitis (EAE), which is 
an animal model of multiple sclerosis (Cantorna 1996).  Vitamin D is known to have 
strong immunoregulatory effects (Provvedini 1983, Bhalla 1983, and Deluca 2001), and 
studies have found that multiple sclerosis patients often exhibit insufficient Vitamin D 
levels (Cosman 1994 and Nieves 1994).  Researchers have also found that periods of low 
vitamin D expression are accompanied by the occurrence of high lesion activity, meaning 
that more demyelinization occurs simultaneously and after periods in which low levels of 
vitamin D are recorded (Auer 2000 and Embry 2000).   
Low vitamin D status has been implicated in the etiology of multiple sclerosis, as 
well as other autoimmune diseases including rheumatoid arthritis, insulin-dependent 
diabetes mellitus, and inflammatory bowel disease.  The level of vitamin D intake 
required to support optimal immune function remains unknown, but is likely to be at least 
the same as that required for healthy bones.  The vitamin D hormone (1,25-dihydroxy 
vitamin D(3)) regulates T helper cell (Th1) and dendritic cell function while inducing 
regulatory T-cell function.  Cantorna and Mahon (2004) concluded that the result is a 
decrease in the Th1-driven autoimmune response and decreased severity of symptoms of 
autoimmune diseases such as multiple sclerosis.   It has been noted that the diet is an 
unreliable source of vitamin D; exposure to sunlight appears to be the most cost-effective 
approach to obtaining adequate levels of vitamin D.  It is believed that one reason 
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prevalence rates of multiple sclerosis are so high in the northern hemisphere and in 
regions far from the equator is that exposure to sunlight and thus, intake of vitamin D, is 
considerably lower in these regions, especially during the winter time.  Interestingly, 
researchers have noted that symptoms of multiple sclerosis fluctuate in severity 
seasonally (Goodkin 1989, Wuthrich 1970, Bamford 1983, Auer 2000).   
In addition, it was determined in a German population that vitamin D status was 
strongly correlated with multiple sclerosis lesion frequency (Embry et al 2000).  
Additionally, Munger et al. (2000) studied vitamin D intake in more than 187,000 women 
from two separate cohorts, one of which was followed for 10 years and the other followed 
for 20 years.  Overall, the risk of multiple sclerosis was 40% lower in women who 
ingested more vitamin D (Munger et al. 2000), although sunlight was not accounted for 
since the women in the study were ingesting vitamin D supplements.  The researchers did 
conclude, however, that vitamin D ingested as a part of regular diet did not affect risk of 
developing multiple sclerosis (Munger et al. 2000).   This research suggests that high 
vitamin D intake, regardless of sunlight exposure, is associated with the reduced risk of 
developing multiple sclerosis.  
The nutritional aspect of multiple sclerosis was studied in relation to the 
latitudinal theory of the disease in an epidemiologic investigation conducted by Esparza 
et al. (1995).  Researchers set out to determine the relationship between multiple sclerosis 
mortality rates during the period 1983-1989 obtained for 36 countries and dietary fat and 
latitude.  The researchers conducted multiple regression analysis to determine the relation 
ship between saturated fatty acids, animal fat, and animal minus fish fat.  They found that 
latitude was positively associated with multiple sclerosis mortality.  The ratio of 
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polyunsaturated fatty acids to saturated fatty acids and the ratio of unsaturated fatty acids 
to saturated fatty acids were negatively correlated with multiple sclerosis mortality.  
These results suggest that dietary fat intake and latitude are positively associated with 
multiple sclerosis mortality (Esparza 1995). 
Furthermore, recent epidemiological studies imply that unsaturated fatty acids 
may have a positive effect on the course of the multiple sclerosis.  Schwarz and Lewleing 
(2005) conducted a meta-analysis of three clinical trials and found that there seemed to be 
a nutritional benefit from linoleic acid associated with development of multiple sclerosis.  
They also found that high intake of vitamin D is associated with lower prevalence rates of 
multiple sclerosis.  However, from their studies, the role of minerals, trace elements, 
antioxidants, vitamins and fish oil remained unclear (Schwarz and Leweling 2005).   
Furthermore, Ghadirian et al. (1998) studied the relationship between nutritional 
factors and incidence of multiple sclerosis in Montreal, Canada from 1992 to 1995.  
Researchers collected dietary information using a survey which was completed by 197 
individuals.  Dietary information was collected by employing a 164-item food frequency 
questionnaire in a face-to-face interview.   It was found that there was an inverse 
association between high body mass index (BMI) and the risk of developing multiple 
sclerosis.  As BMI increased, risk for developing multiple sclerosis decreased, suggesting 
that a fatty diet would be a protective factor against the disease.  Furthermore, a positive 
association was observed for animal fat intake and risk for developing multiple sclerosis, 
and a significant protective effect was observed with other nutrients, including vegetable 
protein, dietary fiber, cereal fiber, vitamin C, thiamin, riboflavin, calcium, and potassium.  
These trends were similar in both males and females when examined separately.  With 
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respect to specific foods (as opposed to nutrients), a higher intake of fruit juices was 
inversely associated with risk, suggesting that as ingestion of fruit juices increased, 
multiple sclerosis incidences decreased.  Finally, a protective effect was also observed 
with cereal/breads intake for all cases combined, but for fish among women only, and 
pork/hot dogs and sweets were positively associated with risk for developing the disease.   
Overall, Ghiardian et al. concluded that their study did support the hypothesis that 
a diet high in natural fruits, vegetables, and grains would have a protective effect on risk 
for developing multiple sclerosis, while the evidence also suggested an increased risk of 
the disease was associated with high intake levels of animal fat.   
Yet another study to determine the relationship between nutrition and multiple 
sclerosis was conducted by Tola et al. (1999).  The results of this case-control study, 
conducted in Italy, suggested that high intakes of bread, pasta, butter and lards, legume 
soup, horse flesh, and caffeine-containing beverages before the age of 15 would result in 
higher risk of developing multiple sclerosis.  However, there was no association between 
intakes of these items and development of the disease after puberty.   
The possible relationship between diet and multiple sclerosis has not been 
subjected to adequate study, and the protective role of nutrients with respect to the 
disease need to undergo further analysis.  However, the epidemiological data suggest an 
association between multiple sclerosis and nutrition.  It seems that populations that take 
in a higher quantity of foods of animal origin (i.e., meat and dairy products) seem to be 
the most affected by the disease.  The role of saturated fatty acids in the progress of 
myelinic damage has been implicated, and some case control studies indicate a time-
cause relationship between the intake of total calories and saturated fats and the incidence 
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of multiple sclerosis.  Meanwhile, other prospective studies failed to confirm this 
hypothesis, yielding results that contradict the protective effect of a diet rich in anti-
oxidant vitamins and polyunsaturated fatty acids.  In patients with a progressive chronic 
form of the disease, polyunsaturated fatty acids did not demonstrate any effect on the 
progression of the invalidating lesions.   
Nutritional interventions have been conducted in patients suffering from an acute 
and remittent form of multiple sclerosis; these interventions have pointed to the 
significant effect of treatment with polyunsaturated fatty acids in slowing down the 
progression of myelinated lesions only in cases with a slight initial degree of disability or 
no disability at all.  However, the interventions seem to confirm the hypothesis of an 
association between the magnitude of the disease and consumption of saturated fats and 
show an improvement trend in patients treated with polyunsaturated fatty acids, although 
the data are not statistically significant.  It appears that the data regarding the nutritional 
theory with respect to development of multiple sclerosis is inconclusive and ambiguous.   
 
Genetics and the development of multiple sclerosis. 
There are two types of evidence that suggest multiple sclerosis is a genetic disease.  
The first type of evidence is derived from population studies.  Multiple sclerosis is a 
disease that affects primarily people of northern European heritage, and other ethnic 
groups tend to be less likely to develop it.  Secondly, evidence from family studies 
indicates that individuals who have cases of multiple sclerosis in family members are 
more likely to develop the disease themselves (Carton 1997).  For instance, the average 
person in the United States has an approximate chance of 1 in 750 of developing the 
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disease; however, people who have relatives with multiple sclerosis have a higher risk of 
developing the disease, ranging from 1 in 100 to 1 in 40 (Carton 1997).  Furthermore, 
researchers have shown that the identical twin of a patient with multiple sclerosis has a 1 
in 3 chance of developing the disease (Mumford 1994, Willer 2003, Hansen 2005, and 
Ristori 2006).  Researchers have concluded from these twin and family studies that 
genetic make-up is important for determining who may develop multiple sclerosis.  
One of the hallmarks of multiple sclerosis is its unequal distribution across the 
globe.  It is most common in populations of northern European descent, and is diagnosed 
most often in Scandinavian nations, the United Kingdom, and the northern United States 
and southern Canada (Compston 1997).  Regions of high prevalence have been found in 
northwestern Sardinia (Sotgiu 2002 and Marrosu 2002) and Sicily (Grimaldi 2001 and 
Nicoletti 2005).  Several areas of abnormally high prevalence of multiple sclerosis have 
been found in Finland, as well.  In these regions, there is an approximately two-fold 
increased prevalence than the national average (Panelius 1969, Wikstrom 1975, 
Kinnunen 1983, and Sumelahti 2000).  Seinajoki, in southern Ostrobothnia, Finland, 
recently demonstrated an incidence of 12 cases per 10,000 people, which is the highest 
rate of multiple sclerosis reported anywhere in the world (Sumelahti 2001).  It has been 
demonstrated that these areas are considered high-risk regions for multiple sclerosis.  
Recently, haplotypes associated with multiple sclerosis have been identified.  Tienari et al. 
(2006) have suggested that such haplotypes could be used as molecular tools for tracing 
common ancestry between patients in separate locations, thus providing clues to 
historical origin of the disease.  Furthermore, researchers have proposed that this 
archealogical genetic approach would help to narrow the size of the haplotype shared 
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between groups allowing for the identification of etiological variants of multiple sclerosis 
patients.   
The evidence from family studies supporting a genetic susceptibility for multiple 
sclerosis is compelling.  Studies have been conducted on twin, half-sibling, and adoptee 
populations of northern European descent, and the results of the studies suggest that 
increased susceptibility to the disease is genetic (Ebers 1995, Willer 2003).  In 
monozygotic twins, there is a 20-30% increased risk for developing the disease, while the 
risk is only 3-5% in dizygotic twins.  Interestingly, in twin studies conducted in France 
and Italy, the concordance rates for both monozygotic and dizygotic twins are reportedly 
6-11% (French Research Group on MS 1992).  The differing results from these two sets 
of studies suggest that the role of genetics in inheriting multiple sclerosis is more 
prominent in populations of northern European descent than in France and Italy.  A 
recent Canadian twin study revealed concordance rates of 34% versus 3.8% in 
monozygotic versus dizygotic female-female pairs and 6.5% versus 11.4% in male-male 
pairs (Willer 2003).  The results in the Canadian twin study suggest that the role of 
genetic factors is more powerful in women than in men.   
The fact that the rate for identical twins both developing multiple sclerosis is 
significantly less than 100 percent suggests that the disease is not entirely genetically 
controlled.  However, this could be due to the fact that some people with multiple 
sclerosis lesions remain asymptomatic throughout their lives.  This could also be due to 
low penetrance of the susceptibility allele of multiple sclerosis.   
 Multiple sclerosis is considered to be a polygenic disease, meaning that multiple 
genes contribute to the development of the disease.  Thus far, no mutation leading to the 
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 Figure 2.  Prevalence of multiple sclerosis in Ostrobothnia compared to surrounding regions   
 (Figure adapted from Tienari 2004). 
disease has been identified.  An association with the HLA-DRB1*1501-DQB1*0602-
DQA1*0102 haplotype is the most common finding in universal molecular genetics 
studies on multiple sclerosis thus far.  The association with HLA is not a new one.  
Although this association has been known for over 30 years, it is still largely unknown 
which of the three associations is the responsible variation, or if it is a combination of 
several of the three variations that leads to the disease.  Few non-HLA loci have been 
found over the years, but the most common ones found in the literature are found on 
chromosome 5p (Ebers 1996 and Kuokkanen 1996), 17q (Sawcer 1996, Saarela 2002, 
and Barton 2004), and 19q13 (Barcellos 1997, D’Alfonso 2000, Pericak-Vance 2004, and 
Reunanen 2002).  The predisposing genes in these regions have yet to be identified.  
Tienari et al. (2004) suggest that some of these genetic data are defined geographically, 
and certain allelic associations appear restricted to southern Ostrobothnia.  In a sub-
region analysis of Ostrobothnia, it was observed that the population area at high risk for 
developing multiple sclerosis was relatively small, the Kyronjoki river region with a 
population of approximately 100,000.  The prevalence for multiple sclerosis in this region 
was 210 per 100,000 in 1993 (Tienari 2004).  Research indicates that the proportion of 
patients with multiple sclerosis is higher in southern 
Ostrobothnia than in neighboring regions or in southern 
Finland (Figure 2) (Sumelahti 2003 and Tienari 2004).   
 Although Finland was not conquered by the 
Vikings, there is archaeological evidence for a Viking 
20 
influence in the southwestern high-risk area of Ostrobothnia (Lehtosalo-Hilander 1982); 
this evidence shows a connection with the Kyronjoki river region,  
and these observations demonstrate the Scandinavian influence in this region, which may 
have been significant in leading to the high rate of occurrence in Finland today (Tienari et 
al. 2004).   
Myelin Basic Protein (MBP) and other haplotype signatures can be used as DNA 
fingerprints to trace common ancestry between patients in different geographic locations.  
It is assumed that MBP can provide clues to the historical origin of multiple sclerosis, as 
well as be an approach to define a “superfamily” of multiple sclerosis patients with 
common ancestry and common pathogenetic mechanisms (Tienari 2006).  MBP would 
help narrow the size of the shared haploytype identical-by-descent, and it would thus 
make it easier to define etiological variants in patients with multiple sclerosis (Tienari 
2006).  Since the stretches of DNA identical-by-descent become smaller as the genetic 
distance of patients increased, more focused high-density single nucleotide 
polymorphism (SNP) and haplotype analyses as well as functional experiments at smaller 
number of candidate sites are allowed.  In other words, as the similarities between 
genomes become greater between groups, it becomes easier to identify portions of the 
genomes that may have mutations which could lead to inheritance of a certain disease.  In 
the case of multiple sclerosis, if a genetic “superfamily” could be identified by comparing 
genomes of northern Europeans and African Americans, for instance, then this would 
indicate that northern Europeans may have passed a genetic susceptibility to African 
Americans if the same similarities between these two groups are not found in Africans 
21 
alone.  This type of analysis would also facilitate the search for the specific genes that 
determine the etiology and risk for developing the disease. 
 Furthermore, genealogical evidence for a founder effect in multiple sclerosis has 
also been reported in Overkalix in northern Sweden (Binzer 1994), in Lysvik parish in 
western Sweden (Callander 2004), and in Sardinia (Marrosu 2002).  A founder effect is 
described as the effect of establishing a new population by a small number of individuals 
who carry only a small portion of the original population’s genetic variation.  The 
resulting population could exhibith different genetic and phenotypic characteristics from 
the original population from which it was derived, and this is what appears to have 
happened in northern Sweden, Sardinia, and Ostrobothnia, Finland.   Additionally, there 
are clusters, or areas of increased incidence or prevalence of a disease which are 
surrounded by regions where risk is not considered to be out of the ordinary, of multiple 
sclerosis in continental Europe, in northern Croatia and western Hungary.  In these areas, 
some rural regions have reported prevalence rates approaching 200 cases per 100,000 
population at risk (Guseo 2004).  Inferences drawn from this data include probable 
genetic isolation and possible Germanic ancestry, which is interesting since many 
Scandinavians have Germanic ancestors (Tienari 2006).   
 The tools for SNP have advanced greatly with the Human Genome and HapMa 
Projects.  Thus far, more than a million SNPs have been analyzed through the HapMap 
Project.  Predisposing variants to multiple sclerosis will most reliably be caught by such 
grand scale associations studies as the HapMap Project (Tienari 2006).   
Genetic research on the inheritance of multiple sclerosis has determined that if a 
person has multiple sclerosis, that person's first-degree relatives (i.e., parents, children 
22 
and siblings) have a 1-3 percent risk of inheriting the disease (Carton 1997).  Although no 
specific gene for multiple sclerosis has been identified, several researchers have 
concluded that people with multiple sclerosis inherit certain regions on individual 
chromosomes more often than people without multiple sclerosis. Researchers are 
investigating the human leukocyte antigen (HLA) on chromosome 6, since the HLA 
patterns of multiple sclerosis patients appear to be different from those who do not have 
multiple sclerosis.  Development of multiple sclerosis is likely to be influenced by the 
interactions of a number of genes, making it a polygenic disease.  It is believed that each 
of the genes ultimately “responsible” for the development of multiple sclerosis has only a 
modest effect.  Researchers continue to conduct studies to pinpoint specific genes that are 
involved in the disease, to determine the function of those genes, and to learn how each 
gene's interactions with other genes make an individual susceptible to multiple sclerosis.  
In addition to leading to better ways to diagnose multiple sclerosis, such studies should 
yield clues to the underlying causes of multiple sclerosis and, eventually, to better 
treatments or a way to prevent the disease. 
Researchers have noted that genes contributing to susceptibility to multiple 
sclerosis are difficult to identify because they exert a relatively modest effect on disease 
risk (Giovananni and Ebers 2007).  The only unambiguous genetic association and 
linkages identified thus far are with alleles of the human leukocyte antigen (HLA) class II 
region, which is a part of the major histocompatibility complex (MHC).  A large linkage 
study conducted on 2692 individuals from 730 multiplex families of northern European 
descent confirmed linkage to the MHC on chromosome 6p21 and suggested possible 
linkage on chromosomes 17q23 and 5q33 (Sawcer 2005).  Another large study of 
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Canadian and Finnish families with multiple sclerosis genotyped 4203 individuals with a 
high-density SNP panel spanning the genes encoding he MHC and flanking genomic 
regions.  These two studies indicate that MHC-associated susceptibility to multiple 
sclerosis is determined by HLA class II alleles, their interactions, and possibly closely 
neighboring variants, and that other regions in the genome are unlikely to contribute 
much to disease susceptibility (Sawcer 2005, Lincoln 2005, Giovannani and Ebers 2007). 
 Multiple sclerosis is currently defined using a set of polythetic criteria, which by 
definition cannot be 100% specific.  Thus, even low rates of misdiagnosis could 
drastically reduce the power of genomic studies to detect loci associated or linked with 
the disease (Cardon 2003).   
Family history remains to be the strongest indicator in multiple sclerosis diagnosis.  
Segregation studies revealed that males with a history of multiple sclerosis in relatives of 
the first and second orders are much more vulnerable to the same disease (Carton 1997).  
In addition, histories of both paternal and maternal relatives have similar predicting 
power, indicating an autosomal transmission of susceptibility (Carton 1997).  Multiple 
sclerosis exhibits a strong racial propensity.   The disease is prevalent among Europeans 
and African Americans, whereas it appears to be rare, sporadic, and random in Asia and 
Africa.  Normally, racial disparity is best explained by inheritance.   
Recently, a whole-genome admixture scan found a candidate locus for multiple 
sclerosis susceptibility.   Admixture mapping is the process of scanning the human 
genome for gene variants that affect risk for developing a disease.  Studying genetic 
markers whose frequencies differ between Europeans and Africans allows for the genome 
of African or European ancestors to be more easily examined so that regions can be 
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identified where individuals with specific diseases, such as multiple sclerosis, have an 
abnormally high concentration of European or African genes (Rife 1954, Chakraborty 
1988, Stephens 1994, Briscoe 1994, McKeigue 1997, and McKeigue 1998).   
According to Smith et al (2004), there are two advantages to admixture scanning.  
First, since African and European immigrants came into contact in North America, there 
has been an average of only six generations of offspring from the two groups.  Smith et al. 
(2004) note that due to the few generations of populations since these groups were first 
introduced in North America, there has been little recombination between chromosomes 
of African and European ancestry in the history of African American populations (Smith 
2004).  Thus, a genome scan tagging all of either the African or the European 
chromosomal segments in a group of African Americans requires only 1,000-3,000 
markers, which is far fewer than the 300,000-1,000,000 markers required for a whole-
genome haplotype scan (Carlson 2003).  The second advantage of admixture mapping is 
that it is much more effective at detecting disease risk variants that are of very low or 
high frequency in Africans or Europeans but are highly differentiated in frequency across 
populations, thus making it a perfect candidate for use in diseases with large racial 
disparities.  Multiple sclerosis is an excellent candidate for admixture mapping due to its 
evident racial disparity between European Americans and African Americans (Kurtzke 
1979).  Therefore, a whole-genome admixture scan was conducted in African American 
multiple sclerosis patients and compared with admixture scans for a group of cases and 
controls.  It was hypothesized that if genetic risk factors for multiple sclerosis explain its 
epidemiology, they would be evident from the admixture scan as identifiable regions of 
high European ancestry in African Americans with multiple sclerosis compared to the 
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control group (Reich et 2005).  As previously mentioned, genetic linkage scans have only 
identified one risk haplotype for multiple sclerosis, which is at HLA on chromosome 6.  
However, according to Reich et al. (2005), admixture mapping, which is considered to be 
an association scan, is much more likely to identify the weak factors that explain the 
disease risk.  By estimating the extent of European ancestry in 605 African Americans 
with multiple sclerosis and comparing their genome scans with those of the genome-wide 
average for cases and controls, Reich et al. (2005) found that the strongest deviation from 
the genome-wide average was on chromosome 1 near the centromere.  Admixture 
association was not detected anywhere else in the genome, and the researchers concluded 
that an immediate priority of multiple sclerosis research should be placed on fine-
mapping the chromosome 1 peak identified in this study to further investigate the 
association between this locus and the risk of developing multiple sclerosis (Reich 2005). 
Table 1.  Key literature reviewed in Chapter II of the present study. 
First 
author 
Year Study 
Hypothesis / 
Subject 
Outcomes Strengths / 
Weaknesses 
Kurtzke 1977 Geography in MS – 
MS is an 
environmental, 
exogenous illness 
High frequency of MS is found 
between 65 and 45º north latitude 
and southern Australia; Latin 
America, Asia, and Africa have low 
risk.  All areas with high risk are in 
Europe or European colonies, thus it 
appears MS spread from western 
Europe.  MS is less common in 
African Americans, Japanese 
Americans, and Amerindians than in 
Caucasians in the US 
Study is still used as basis 
for geography and MS 
information. 
Study is old, published in 
1997. 
Findings contradict the 
geographic theory of MS 
because at 40º latitude, 
MS was found to be high 
in America, medium in 
Europe, and low in Asia 
Rosati  1996 Epidemiological 
studies from Sardinia 
since 1975 indicate 2 
fold increased 
prevalence of MS 
than in surrounding 
areas.  Previous 
populations too small 
to draw conclusions. 
Frequency of MS was studied in 
northwestern Sardinia in a population 
of 270,000 and compared to other 
Italian populations.  Confirmed 
higher frequency of MS among 
Sardinians and attributed rates to 
environmental and genetic factors. 
Confirmed high rate of 
MS in an otherwise low 
frequency area close in 
proximity to the equator.  
Findings contradict the 
geographic theory of MS. 
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First 
author 
Year Study 
Hypothesis / 
Subject 
Outcomes Strengths / 
Weaknesses 
Munger  2000 Study of the 
protective effect of 
vitamin D on risk of 
MS. 
Dietary vitamin D intake was 
examined in 2 large cohorts (the 
Nurses’ Health Study 1980-2000 and 
1991-2001).  Intake of vitamin D 
supplements was inversely associated 
with MS risk.  No association was 
found between vitamin D from food 
and MS incidence.   
Results support a 
protective effect of 
vitamin D intake on risk 
of developing MS. 
Esparza 1995 Ecologic study of 
relation between MS 
mortality rates from 
1983-1989 of 36 
countries and dietary 
fat and latitude. 
Stepwise multiple regression analysis 
determined that saturated fatty acids, 
animal fat, animal minus fish fat, and 
latitude correlated independently and 
positively with MS mortality.   
Findings support 
hypothesis liking dietary 
fat intake and latitude to 
MS mortality.  Inuit diet 
of mainly animal meat 
was not taken into 
consideration. 
Ghadirian  1998 Nutrition and food 
patterns, specifically 
high intake of animal 
fat and low intake of 
fish play a role in 
etiology of MS. 
Nutritional factors and MS studied in 
197 incident cases and 202 controls 
in Montreal between 1992-1995.  
Dietary information was collected by 
164-item food questionnaire and 
interview.  Inverse association was 
observed between BMI and risk of 
MS.  Tall women showed greater risk 
for MS.  Protective effect observed 
with vegetable protein, dietary fiber, 
vitamin C, thiamin, riboflavin, 
calcium, and potassium.  High intake 
of fruit juice inversely associated 
with risk. 
Results support protective 
role for some components 
commonly found in fruits, 
vegetables, and grains, 
and increased risk was 
associated with high 
animal food intake.  
Native diets were not 
taken into consideration. 
Sumelahti 2001 Investigation of 
prevalence trends in 
western and southern 
Finland from 1983-
1993. 
Age-adjusted and age-specific MS 
prevalence rates were calculated.  A 
1.7-fold increase was found in 1993 
when compared to 1983 prevalence 
rates in Seinajoki, Finland.  
Prevalence and incidence in this 
region among the highest reported in 
the world. 
Seinajoki, Finland region 
linked with Scandinavian 
migration.  Highest 
reported incidence and 
prevalence indicates that 
MS may have originated 
in the area. 
Willer  2003 Longitudinal study of 
MS concordance 
rates in twins and 
siblings. 
Concordance rates of 25.3% for 
monozygotic and 5.4% for dizygotic 
twins.  2-fold increase in risk to DZ 
twins of non-twin siblings of twins. 
Demonstrates genetic and 
familial facets of MS.   
Tienari  2006 Geographic and 
genetic summary of 
MS. 
Genetic studies identified haplotypes 
associated with MS patients in 
Finland suggesting a founder effect.  
Haplotypes can be used to trace 
common ancestry and geographic 
origin of MS.   
Demonstrates genetic 
archeological approach to 
define a “superfamily” 
could implicate etiology 
of MS. 
Reich 2005 Whole genome 
admixture scan to 
find a candidate 
locus for MS 
susceptibility. 
Admixture scan focused on 605 
African American cases and 1,043 
African American controls and 
reported a locus on chromosome 1 
significantly associated with MS. 
Demonstrates ability to 
find susceptibility allele 
by examining “new” 
populations with only 
partial European ancestry.  
27 
  
CHAPTER III 
METHODS AND PROCEDURES 
 
In this study, published data from public records and multiple sclerosis prevalence 
estimates from governmental and institutional sources were collected.  In addition to 
extracting data from the literature, related information on multiple sclerosis prevalence 
was obtained from various web publications, including those of the World Health 
Organization (WHO), the Centers for Disease Control and Prevention of the U.S. 
Department of Health and Human Services (CDC), and the Multiple Sclerosis 
International Federation (MSIF).  From these databases, only the statistical information 
covering the last 10 years was extracted for this analysis.  The National Institutes of 
Health website, PubMed, as well as internet search pages were used to collect data, and 
searches were conducted using phrases including, but not limited to multiple sclerosis 
and genetic etiology, multiple sclerosis and environment, multiple sclerosis and nutrition, 
multiple sclerosis epidemiology, and distribution of multiple sclerosis.   
Incidence is defined as the proportion of new cases in a population at risk for 
developing multiple sclerosis divided by the size of the population at risk.  Prevalence is 
defined as a measure of the total number of cases in a population, rather than the rate of 
occurrence of new cases, divided by the population at risk.  In this project, primarily 
prevalence data were collected and used for analysis; however, in some cases incidence 
data was used.  For instance, in First Nations Canadians, only incidence rates were found 
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in the literature.  In these cases, the incidence rates were described in lieu of prevalence 
rates.  When incidence data was used in this report, this fact is clearly stated so that 
prevalence is not to be confused with incidence.  Additionally, some of the data sources 
reviewed in this project had differing incidence or prevalence rates for the same country.  
In such cases, registry data obtained from MSIF were used in the analysis in lieu of 
sample data.  Registry information from MSIF was selected over sampling information 
because in some cases, sampling measures are not necessarily indicative of the 
prevalence of multiple sclerosis for an entire region.  It appeared in all cases reviewed in 
this project that registry data were more comprehensive than sample data. 
An investigation was performed by collecting and reviewing relevant literature on 
worldwide multiple sclerosis prevalence.  Literature citing different explanations for the 
etiology of multiple sclerosis, including geographic, nutritional, and genetic theories for 
the etiology of the disease, were examined and summarized for this project.  Some of the 
literature reviewed that listed key findings and implications related to this project was 
tabulated, and the table was inserted in Chapter II of this project.   
The 2006 edition of the U.S. Central Intelligence Agency World Factbook was 
used to obtain racial and ethnic information for this analysis.  For the purposes of this 
study, Caucasians are defined as white individuals with northern European ancestry; 
African Americans are defined as black individuals living in America whose ancestors 
originated in Africa; Asian Americans are defined as Americans whose ancestors 
originated in China, India, Japan, Taiwan, and Vietnam.  In addition to history textbooks 
and archeological and anthropological literature, information on the migration, settlement, 
and admixture history of different racial and ethnic groups was obtained from the World 
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Factbook, from the free-content encyclopedia Wikipedia, from historical textbooks as 
referenced, and from many other websites dealing with historical aspects of nations.   
Prevalence rates obtained from the MSIF database and Rosati’s 2001 article from 
Neurological Science entitled “The prevalence of multiple sclerosis in the world: an 
update” were gathered for 77 nations, and the information was tabulated in order from 
greatest prevalence to least prevalence (Table 2).  Asterisks note that the prevalence rate 
for the corresponding country was not obtained from MSIF, but rather from a literature 
source, and that source is duly noted.   Three charts were derived from the data listed in 
Table 2.  Data were separated into geographic areas as follows: Europe and Eastern 
Europe, including Russia; the Middle East, the Far East, New Zealand, and Australia; and 
North America, South America, and the Caribbean, and Figures 4, 5, and 6 demonstrate 
these findings.  Following tabulation of the data, prevalence of multiple sclerosis for each 
nation was mapped manually on an editable outline map.  Each nation was identified on a 
world map (Figure 7) and on a European map (Figure 8), found on the editable map, and 
then filled with a color corresponding to the prevalence rate as listed in the figure legend.  
Editable outline maps in Mercator projection in the Powerpoint format were obtained 
from Dr. Ruoxiang Wang, Assistant Professor of Urology at the Emory University 
School of Medicine.  The Red-Green-Blue (RGB) color scheme was used to construct a 
continuous color spectrum to represent multiple sclerosis prevalence from ≤ 19 × 105 
(green color: red, 0; green, 255; and blue, 0) to ≥ 150 × 105 (black color: red, 0; green, 0; 
and blue, 0).  The outline of each nation was filled with the color that represented the 
prevalence of multiple sclerosis in that nation.  Furthermore, in Figure 7, blue arrows 
depict the Northern European migration routes, orange arrows depict Iberian, or Spanish 
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and Portuguese, migration routes, and green arrows depict African migration routes. In 
Figure 8, arrows were drawn depicting the Germanic Migration and Expansion from 750 
BC to 600 AD (pink arrows), the Norsemen, or Viking, migration from 790 AD to 1090 
AD (green arrows), and the Crusades from 1095 AD to 1272 AD (black arrows).  Arrows 
were drawn based on historical data found in textbooks and on Wikipedia.com 
(Christiansen 2006, Encyclopedia Britannica 2007, Hoerder 2002, Wikipedia 2007a, b, c, 
and d).   
 
Data obtained from the Multiple Sclerosis International Federation 
Results regarding the global occurrence of multiple sclerosis obtained from MSIF 
and additional publications indicate that although incidence of multiple sclerosis 
fluctuates on a yearly basis, the rate and trend for each nation remains relatively constant 
when compared to international data.  The MSIF was especially useful in providing 
detailed international surveillance on multiple sclerosis prevalence rates.  Specifically, 
the European Map of Multiple Sclerosis Database provided multiple sclerosis prevalence 
in 64 nations in the year 2006, a set of simplified but comprehensive statistical data 
informative of multiple sclerosis prevalence on a global scale.  To date, the database 
consists of prevalence reports for 64 countries worldwide, but it is reported that another 
32 will be added soon.  Data from another 13 countries were added to this analysis using 
information collected from the literature.   
The information and data contained in the MSIF Atlas of Multiple Sclerosis web 
application were collected using a questionnaire developed by MSIF, the WHO, and a 
number of multiple sclerosis professionals.  The data were chosen because the 
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methodologies for obtaining the data were clearly outlined, well researched, and appeared 
to be reliable based on the collection methods and follow-up conducted by researchers.   
MSIF expresses the prevalence of multiple sclerosis in each nation as a rate of 
cases per 100,000 population at risk.  Upon collection of the MSIF questionnaires, which 
were sent to 98 countries worldwide, the responsive data from 64 countries were 
standardized and organized.  MSIF compiled the responses, and took population data 
from the WHO’s World Health Report 2000 to create an electronic database of global 
prevalence rates of multiple sclerosis, which is now accessible by the public as the 
European Map of Multiple Sclerosis Database at 
http://www.europeanmapofms.org/emsp.aspx.  Other sources for prevalence figures used 
in this analysis are directly referenced herein.   
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CHAPTER IV 
RESULTS 
 
The hypothesis of the current proposal is that since multiple sclerosis occurs 
frequently in certain racial and ethnic groups, and since most nations of the world consist 
of a single racial group as the predominant racial group, a comparison of multiple 
sclerosis prevalence rates among nations would help to determine whether the disease 
coincides with migration, settlement, and admixture of an ethnic group that may carry 
certain susceptibility alleles. 
After conducting a comprehensive review of the literature related to the different 
theories on the etiology of multiple sclerosis and compiling a table of global occurrence 
of the disease, the results indicate that multiple sclerosis prevalence does indeed 
correspond with the migration and settlement history of northern Europeans.  The 
migration and settlement history of the Scandinavians, along with information regarding 
current global incidence or prevalence rates, depending on the information found for each 
country, is detailed below. 
 
European multiple sclerosis prevalence and migration history of the Scandinavians. 
Due to the global disparity in multiple sclerosis distribution, the present research 
project set out to investigate the existing multiple sclerosis prevalence data using a 
geographic epidemiological approach.  The overarching hypothesis of the present study is 
that multiple sclerosis prevalence reflects a susceptibility genotype in individual 
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populations, and the susceptibility allele originated in the population of the highest 
prevalence and was distributed to other racial and ethnic groups through admixture.  The 
genetic epidemiology of cystic fibrosis, hemochromatosis, and prostate cancer has shown 
that inter-group breeding may lead to spreading of the susceptibility alleles to other racial 
and ethnic groups (Sandblom et al. 2003, Higgins et al. 2005, Gilbert et al. 1995, and 
Acton et al. 2001).  If this is truly the case, then the geographic distribution of the varied 
frequencies of a disease reflects the history of migration, settlement, and admixture of the 
population carrying the susceptibility. 
In the present analysis, it was found that nations with the highest prevalence of 
multiple sclerosis are located in northern Europe.  Table 2 and Figures 7 and 8 illustrate 
that other nations with comparable prevalence rates of multiple sclerosis are Canada (100 
cases per 100,000 at risk), the United States of America (135 cases per 100,000 at risk),  
Scotland (187 cases per 100,000 at risk), Australia (78 cases per 100,000 at risk),  and 
New Zealand (85 cases per 100,000 at risk),   The residents of these nations share a 
common origin; most of these nations’ residents are immigrants from northern Europe.  
However, it should be noted that the indigenous Native Americans of North America, the 
Aboriginals of Australia, and the Maoris of New Zealand, who inhabit similar 
geographical environments as the descendents of northern Europe, are rarely diagnosed 
with multiple sclerosis (Warren et al. 2007, Miller et al. 1986, Alter et al. 1971, Fawcett 
and Skegg 1988, and Hornabrook 1971, National Multiple Sclerosis Society 2007).  This 
observation suggests that, at least in the U.S., Australia, and New Zealand, the high 
prevalence of multiple sclerosis accompanied the northern European immigrants during 
their migration, and this co-migration suggests that multiple sclerosis is almost certainly 
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an inherited disease which originated in northern Europe.  To demonstrate how this co-
migration may have occurred, it is important to map out the migration of the northern 
Europeans and to investigate the potential relationship between their migration and the 
current prevalence of multiple sclerosis.  
 Multiple sclerosis prevalence data for 77 European nations are available from 
MSIF and other sources in the literature.  A gradient distribution of multiple sclerosis 
prevalence is a salient geographic epidemiological feature in Europe.  With the highest 
prevalence in northern Europe appearing in Norway, high rates of multiple sclerosis 
prevalence spread along the coast of the northern Atlantic Ocean to all of the Western 
European nations (Figure 7).  Prevalence of multiple sclerosis declines gradually in 
nations as they become more distant from Norway. 
 In addition to Norway, the other Scandinavian neighbors, Finland, Denmark, and 
Sweden, each have high prevalence rates.  In general, with Norway as the apex, high 
multiple sclerosis prevalence radiates to the south and west to nations bordering the 
North Atlantic Ocean.  This radiation covers the west half of northern Europe, countries 
including Sweden, Finland, Norway, Iceland, United Kingdom, and Ireland, all of 
western Europe (i.e., Germany, the Netherlands, Belgium, Lithuania, France, Austria, and 
Switzerland), and the west part of southern Europe (i.e., Italy, Spain, and Portugal).  
Following this pattern, multiple sclerosis prevalence appears inversely proportional to the 
respective country’s distance from Norway (Figure 8).  On the other hand, the inland 
portion of Europe, central and eastern European nations, as well as those in southeast 
Europe, shows markedly reduced multiple sclerosis prevalence, even though the distance 
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from Norway is essentially the same as the Western Europe nations (Figure 8), and the 
geographic latitude of these nations is similar, as well. 
 This gradient of multiple sclerosis prevalence rates in northern and western 
European nations is well recognized, and the relatively reduced multiple sclerosis 
prevalence in the rest of Europe is also well known.  To date, however, there has been no 
satisfactory explanation for this phenomenon.  Interestingly, European nations cohabit in 
a relatively similar geographic environment with similar levels of exposure to sunlight, 
similar climate, etc.  Meanwhile northern and western Europeans enjoy the highest 
standard of living together with affordable medical care.  Yet, cause for the high multiple 
sclerosis prevalence among these nations remains unknown. 
 As noted in the literature review, there are a number of theories regarding the 
reasons for the gradient of multiple sclerosis prevalence rates.  None of the theories 
mentioned above can fully or conclusively explain the global distribution of multiple 
sclerosis.  The geographic, or latitudinal theory, was discounted with the examination of 
multiple sclerosis incidence in Sassari, Sardinia.  The latitudinal theory stated that as the 
distance from the equator increased, so did prevalence of multiple sclerosis, presumably 
due to the decrease in vitamin D intake.  After investigating the incidence of multiple 
sclerosis in Sassari as well as in other parts of Europe and Italy, researchers concluded 
that the incidence of multiple sclerosis in Sassari was much higher than it would be 
expected to be if the latitudinal theory fully explained the distribution of the disease 
(Pugliatti 2001).   Furthermore, Marrosu et al. (2002) examined the presence of familial 
aggregation in Sardinian patients with multiple sclerosis by investigating the recurrence 
risk in siblings of individuals affected with the disease.  They evaluated factors 
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influencing risk, such as patient and sibling sex, patient age at onset, sibling birth cohort, 
and the presence of affected relatives other than siblings.  To establish the contribution of 
genetic factors to familial multiple sclerosis aggregation, the researchers verified the 
presence of distant familial relationships among patients, tracing the extended pedigrees 
of all multiple sclerosis patients born in the Sardinian village described by researchers as 
“L.”, which, according to Marrosu et al. (2002) could be considered a “genetic drift” on a 
microgeographic level.   L.’s population showed little variation from the first census at 
the end of 1600 to 2001 when the study was conducted, in the absence of substantial 
admixture from nearby villages as reported from precise historical sources.  Marrosu et al. 
(2002) showed that the ratio between lifetime risk for a sibling of a patient with multiple 
sclerosis divided by risk in the general population in Sardinians is similar to that reported 
in populations of Scandinavian descent.  Furthermore, it was found that that recurrence 
risk in siblings of patients with multiple sclerosis varies widely according to the age at 
onset of the disease and whether there are other affected family members.  According to 
the researchers, this finding suggests some degree of heterogeneity in the genetic 
mechanisms underlying familial aggregation.   However, pedigrees of patients from the 
village of L., demonstrating that all affected subjects descended from three pairs of 
ancestors, substantiated a “founder effect” as responsible for the disease in the village and 
confirmed that Sardinian familial aggregation of the disease is genetic in nature (Marrosu 
et al. 2002).  It is important to note that these findings support a genetic etiology of the 
disease.   
 Furthermore, the latitudinal theory is discounted with evidence showing that 
Native Americans who currently live in the same latitudinal geographic area as other 
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racial groups in the northwestern United States, do not exhibit the same high prevalence 
of multiple sclerosis as the latter group (Warren 2007).  Although most native 
populations in North America have historically been nomadic, moving from one 
geographic latitude region to another, and probably originated in Eurasia, to date, there is 
no evidence in the literature that these groups have ever experienced moderate or high 
levels of multiple sclerosis.  This trend of natives exhibiting lower prevalence and 
incidence rates of multiple sclerosis than migrants living in the same country can be seen 
in almost any nation where northern Europeans have traveled and settled among natives 
of the respective region (Kurtzke 1977).   
 Judging from Figure 7 it has become evident that elevated levels of multiple 
sclerosis prevalence are found mostly in coastal nations, and since northern Europeans 
conducted much of their exploratory traveling through maritime routes, it is not 
surprising that rates of multiple sclerosis are higher near the coasts where explorers 
would have migrated and settled.  By examining the geographic distribution of multiple 
sclerosis prevalence rates in Europe, data from the present study indicate that 
susceptibility to multiple sclerosis is closely associated with the migration and settlement 
history of northern Europeans and that the prevalence gradient in Europe results from 
admixture of the Scandinavians with racial and ethnic groups in other parts of Europe.  
Subsequently, the susceptibility allele for developing the disease was transmitted to other 
races and ethnic groups throughout the migration and settlement history of the Europeans 
by interracial admixture.  This investigation indicates that there is indeed a genetic 
susceptibility to multiple sclerosis, that the susceptibility originated in Scandinavia, and 
that the alleles have been transmitted by gene flow to other races. 
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 The southward migration of the northern Europeans is well documented 
(Wikipedia 2007a, b, c, d and MSN Encarta 2007).  Three successive waves of southward 
migration have been chronicled; the earliest of which was the Germanic Migration and 
Expansion from 750 BC to 600 AD (Encyclopedia Britannica, Wikipedia 2007d).  During 
the Migration and Expansion, Germanic tribes in southern Scandinavia settled in 
continental Europe and the British Isles located in the North Atlantic Ocean 
(Encyclopedia Britannica 2007, Wikipedia 2007d).    This wave of migration was 
followed by the Norsemen Migration from 790 AD to 1090 AD (MSN Encarta 2007).  
Since the Vikings had such advanced technology and navigational skills, it was natural 
for them to have traveled using maritime routes.  They traveled mainly along the coast of 
the North Atlantic Ocean, through the Straits of Gibraltar to the Mediterranean Sea 
(Figure 8).  In comparison, far fewer Scandinavians traveled into the inland area using 
other means of transportation (Christiansen 2006, MSN Encarta 2007).   
 The third wave of migration, known as the Crusades from 1095 AD to 1272 AD, 
consisted of large numbers of northwestern European men traveling to the Middle East 
(Hoerder 2002, Wikipedia 2007b).  It is possible that at the end of the two thousand years 
of southward migration, settlement, and admixture, the original Scandinavian genetic 
attributes had been transmitted along maritime routes to the British Isles and the 
northwestern regions of continental Europe.  Subsequently, genetic attributes were further 
transmitted to other parts of Europe to form the northern European genetic gradient of 
multiple sclerosis currently demonstrated.  It is important to note that this gradient is 
congruous with the current gradient in geographic distribution of multiple sclerosis 
prevalence, suggesting that the susceptibility to multiple sclerosis is one of the genetic 
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attributes that originated in southern Scandinavia, and was transmitted to other European 
ethnic groups by admixture.  
 The geographic distribution of multiple sclerosis prevalence coincides with the 
migration routes of the Scandinavians, and the gradient of the prevalence also reflects the 
extent of Scandinavian settlements.  Scotland and the United Kingdom, for example, are 
populated mainly with Scandinavians and the prevalence rates of multiple sclerosis there 
are reportedly among the highest in the world, making the prevalence rates in these two 
regions comparable to the levels of multiple sclerosis in Scandinavia.  Furthermore, it is 
also known that Iceland was a frequent migration and settlement place for the 
Scandinavians, and currently, the country exhibits substantial prevalence rates of multiple 
sclerosis (Wikipedia 2007b and d). 
  
Global multiple sclerosis and European migration, settlement, and admixture. 
Due to the consideration that the gradient of multiple sclerosis prevalence in 
Europe may be a result of genetic admixture of the northern Europeans with other races 
and ethnicities, further analysis was performed in order to trace a potential link between 
the Europeans and high multiple sclerosis prevalence rates in other parts of the world. 
The high prevalence rates of multiple sclerosis in Canada, the United States of 
America, Australia, and New Zealand could be due to migration and settlement by 
northern Europeans and their descendents.  These nations were once again settled by 
northern Europeans in relatively recent historical times.  Thus, it is possible that people 
migrating from Europe may have carried the multiple sclerosis susceptibility allele to 
Australia, New Zealand, and North America 
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 Europeans began to migrate to the New World, or the United States, on a large 
scale in the 15th century, 700 years after the Scandinavians settled in different parts of 
Europe (The Library of Congress 2007).  Currently, most of the residents in the U.S. are 
European migrants, their descendents, and the offspring of admixture between Europeans 
and Native Indians.  Furthermore, emigrants from European countries often settle in 
regions where earlier emigrants from their native land have settled. 
 According to the data listed in Table 2, the national multiple sclerosis prevalence 
rates in the United States and Canada parallel those in the European countries where 
European Americans originated.  Most of the European Americans in North America 
originated in northwestern Europe where the prevalence of multiple sclerosis is high.  It 
is evident that both Canada and the United States of America have rates of multiple 
sclerosis comparable to the rates in northwestern Europe (Table 2, Figure 7).  On the 
other hand, Central and South American countries, where the population majorities are 
descendants of the admixture between native Indians and Spanish or Portuguese colonists, 
exhibit much lower rates of the disease.  Throughout history, the Spanish and Portuguese 
settlers of Central and South America divided the region into two separate territories.  It 
is interesting to note that the South American countries (i.e., Peru, Mexico, Brazil, and 
Argentina) settled by the Spanish and Portuguese have relatively low prevalence rates of 
multiple sclerosis, as do Spain and Portugal when compared to their bordering nations. 
 The Caribbean countries have a complex history of colonization by several 
different European powers.  Both the Scandinavians and the western Europeans colonized 
parts of the Caribbean at one point or another.  In addition, European colonists brought 
Africans into this area by participating in the Slave Trade.  During the Slave Trade, 
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admixture between the Europeans and the Africans was extensive and complete, meaning 
that much of the time, Africans were not permitted to mate with people of their own race.  
Furthermore, admixture was unidirectional in that it was the Caucasian men who were 
mating with African women, rather than African men breeding with Caucasian women.  
Thus, any genetic mixture between Africans and Caucasians would have been passed 
from African mothers to their offspring.  Many of the Caribbean countries now exhibit 
relatively high multiple sclerosis prevalence rates, even though most of their current 
inhabitants originated in Africa where multiple sclerosis is considered a rare disease.  For 
instance, Barbados reported prevalence of 26.3 cases per 100,000 at risk; Cuba reported 
10 cases per 100,000; and Martinique reported 14 cases per 100,000.   
 Furthermore, the relatively high incidence of multiple sclerosis in African 
Americans is an important issue affecting multiple sclerosis research.  Since the rate of 
multiple sclerosis in Africans is considerably lower than in African Americans, it is 
evident that Africans are much less susceptible to the disease.  Family history is a strong 
risk factor for developing multiple sclerosis in African American populations indicating 
that the disease may also be an inherited disease in this population (Multiple Sclerosis 
Genetics Group 1998).  Since African Americans could not have inherited multiple 
sclerosis from their African ancestors who show low rates of the disease, it seems that 
African Americans must have contracted the susceptibility allele from another source.  
To identify that source, the epidemiology of multiple sclerosis in Africa was examined. 
 Unfortunately, nations in Africa have a limited life expectancy and the healthcare 
systems in Africa are less advanced than in the rest of the world.  Few African nations 
reported multiple sclerosis prevalence rates to MSIF.  Generally, researchers contend that 
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Africa exhibits much lower levels of multiple sclerosis than Europe and the Americas 
(Kurtzke 1977, Kurtzke 2000, Rosati 2000, Oksenberg 2004, Elian and Dean 1987, and 
Modi 2001).   
 It is interesting to note that in addition to the much lower rate of multiple sclerosis 
afflicting people in Africa, the distribution of the disease is greatly scattered.  South 
Africa exhibits a higher multiple sclerosis prevalence than Tunisia and Libya, which are 
farther from the equator, but were settled by northern Europeans later than South Africa 
(Wikipedia 2007c).  It appears that multiple sclerosis prevalence rates reported in Africa 
are not distributed uniformly; however, there have been few reported prevalence rates on 
the continent.  It is unknown whether this is because there are no cases to report, or if the 
less than mediocre healthcare system is not capable of diagnosing the disease.   The 
highest prevalence of the disease in Africa has been reported in South Africa, where the 
British influence is highest and where there are many English-speaking inhabitants; 
meanwhile, no prevalence has been reported in inland Africa (Figure 7).  In Libya, it 
appears that the highest prevalence is demonstrated in the coastal region, whereas lower 
prevalence has been reported from inland Libya.  This could be indicative of the longer 
settlement history along the coast since the area was settled through maritime travel.  
Tunisia reported an prevalence rate of 10 cases per 100,000; Libya reported 9 cases per 
100,000 in Kelibia, which borders the Mediterranean Sea, while Benghazi, further inland 
reported prevalence of 6 per 100,000 (Attia Romdhane 1993, and Radhakrisnan 1985).  
Additionally, 15 cases per 100,000 people at risk were reported in the Canary Islands 
(Ben Hamida 1977).  For many years, physicians working in the region claimed that there 
were no cases of multiple sclerosis in sub-Saharan African nations (Poser 1996).  
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However, Poser (1996) reported that there was evidence of several cases of multiple 
sclerosis in black Africans in Senegal, although there were only 4 cases with autopsy 
evidence; still, it appears that the prevalence was incredibly rare.  South Africa, on the 
other hand, has reported a relatively high prevalence of the disease (13 cases per 100,000 
in English Speaking Caucasian south Africans, 4 cases per 100,000 in Afrikaans-
speaking Caucasian Africans, and 3 cases per 100,000 in back South Africans), given that 
its neighboring countries have reported that multiple sclerosis is virtually non-existent 
within their borders (Dean 1967, Dean et al. 1994, and Kies 1989).  Moreover, MSIF 
(2006) reported that the prevalence rate was 32 per 100,000 at risk in South Africa.  The 
fact that multiple sclerosis appears to be more common in coastal regions in Africa, such 
as Tunisia, the Canary Islands, and South Africa and less common in inland Africa based 
on the lack of data coming out of the region and the observations by physicians that the 
disease is virtually non-existent there, supports the premise that genetic admixture led to 
the susceptibility of some, but not all Africans, given that admixture with Northern 
Europeans was more likely to have occurred in the coastal nations due to their maritime 
trade and migration routes (Poser 1996 and Rosati 2001).   
 The current research suggests that multiple sclerosis prevalence in these regions 
of Africa is associated with the history of European colonization.  The history of 
European trade, migration, and settlement in Africa is well documented (Wikipedia 
2007c).  Five hundred years ago, Portuguese ships began exploring the Atlantic Coast.  
The Dutch and the British began to settle in Africa, after the Portuguese journeys, in the 
early 17th century along the same maritime route as the Portuguese (Wikipedia 2007c).  
The Dutch and the British first settled in the coastal regions of western and southern 
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Africa, and then moved inland.  By the early 20th century most of Africa had become 
colonies of western European nations.  Historically, Europeans traveled along the coast of 
the Indian Ocean much less frequently than they traveled along the Atlantic coast 
(Wikipedia 2007c).   
 There appears to be an association between the migration and settlement history 
of the Europeans and the geographic distribution of the elevated prevalence rates of 
multiple sclerosis on the continent of Africa (Figure 7).  This observation suggests that 
Scandinavian admixture with other Europeans may have relayed a transmission of 
genetic susceptibility to multiple sclerosis to northern and South Africans over time.  
However, it is impossible to draw any conclusions about the incident rates in the interior 
of Africa since no prevalence has been reported in this region. 
 While European admixture with Africans in Africa is regional and historically 
transient, the European admixture with Africans in the Americas is historically thorough 
and permanent.  In the past in the Americas, gene flow between northern Europeans and 
the Africans was mostly unidirectional from the former to the latter (Cavalli-Sforza et al. 
1994 and Abe-Sandes 2004), and present day African Americans carry a substantial 
amount of the European genome (Sans et al. 2002, Sans et al. 2000, and Chakraborty 
1992).  Thus it seems possible that the genetic susceptibility to multiple sclerosis could 
have been transmitted from the Europeans to the African Americans. 
 According to the Mendelian theory of transmission of susceptibility alleles by 
admixture, it would be possible to increase the susceptibility to a disease in the recipient 
population, but the prevalence in the recipient population would not surpass that of the 
donor population unless additional additive or synergistic factors existed.  If African 
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Americans inherited the susceptibility to multiple sclerosis from northern Europeans, 
then they should have an elevated multiple sclerosis prevalence with respect to that of 
native Africans.  However, the prevalence of the disease in the African American 
population would still be lower than, or at most equal to, the northern Europeans.  With 
this rationale, multiple sclerosis prevalence in African Americans was compared with that 
of European Americans.  It was found that African Americans develop multiple sclerosis 
less frequently than European Americans (Bailey 1922, Alter 1962, Oh 1969, and 
Kurtzke 1979).  A recent study indicated that African Americans had a relative risk of 
0.64 for developing the disease compared to their European American counterparts 
(Wallin 2004).  This observation suggests that African ancestry may indeed act as a 
protective effect against multiple sclerosis, but it appears that the increased prevalence of 
multiple sclerosis in African Americans compared to native Africans could be due to 
admixture of the resistant African population with the susceptible European American 
population.   
 Travelers from Scandinavia first explored the Western Hemisphere more than a 
thousand years ago (The Library of Congress 2007).  However, true settlement of North 
America by Scandinavians began in the 17th and 18th centuries when wealthy 
Scandinavians sought religious and political freedom in North America.  By the 19th 
century, the great migration of Scandinavians to the U.S. took place.  Once in America, 
most of the immigrants from Sweden, Norway, Denmark, and Finland chose to settle 
primarily in the Midwest.  They were drawn to the Midwest by the promise of open land, 
and many of the emigrants were recruited by railroad companies and local governments 
to settle remote parts of the country (The Library of Congress 2007).  If the current 
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theory of transmission of a susceptibility allele for multiple sclerosis is true, it would be 
likely that the Midwest regions of America would have some of the highest rates of 
multiple sclerosis today. 
 According to Wynn et al. (1990), Olmstead County, Minnesota currently exhibits 
the highest prevalence of multiple sclerosis in the United States at 160 cases per 100,000.  
Additionally, Galion city, Ohio, and Mower County, Minnesota have reported very high 
prevalence rates at 112 and 100 cases per 100,000 population at risk, respectively 
(Hopkins 1991 and Kranz 1983).  These rates are considerably higher than rates reported 
by other parts of the country.  For instance, Los Angeles, California reported a prevalence 
of 22 per 100,000 population at risk (Visscher 1977); King-Pierce Counties, Washington 
reported 69 cases per 100,000 at risk (Visshcher 1977); 65 cases per 100,000 were 
reported for Weld-Larimer Counties, Colorado (Nelson 1986); and 76 cases per 100,000 
reported in Los Alamos County, New Mexico (Hoffman 1981).  Interestingly, Key West, 
Florida reported a prevalence rate of 110 cases per 100,000 population at risk in 1983 
(Sheremata 1985).  It should be noted that this area of Florida was primarily settled by 
the Spanish, who exhibit elevated levels of multiple sclerosis, but not as elevated as the 
Scandinavians.  
 It appears that the geographic distribution of multiple sclerosis in the United 
States is definitely influenced by the varying genetic susceptibility to the disease between 
racial and ethnic groups.  In 1976, a national survey of multiple sclerosis reported 
prevalence rates among Caucasians to be 49, while the same survey revealed that 
prevalence among non-Caucasians was 26 (Baum 1986).  In addition, a study of U.S. 
Army veterans demonstrated that the risk of African Americans developing the disease 
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was half that of Caucasian Americans, and the risk was even lower in Asians and 
American Indians (Kurtzke 1979).  Furthermore, a study conducted in Hawaii indicated 
that the prevalence rate for multiple sclerosis in Caucasians was 26 per 100,000 at risk, 
while the prevalence for Asians was 9 (Alter 1971).   
 
Multiple sclerosis prevalence in the Middle East and migration history of the northern 
Europeans. 
 Data from the Middle East regarding multiple sclerosis prevalence indicate that 
the disease is high in some parts, and very low in others.  Israel reported the highest 
levels of the disease, but the data were difficult to interpret.  In the northern region of 
Israel, reports ranged from 29 to 38 cases per 100,000.  Meanwhile in southern Israel, 
near Jerusalem, rates ranged from 51 to 68 per 100,000.  Kahana et al. (1994) examined 
multiple sclerosis prevalence among native-born Israelis.  It was found that the rate of 
multiple sclerosis in native-born Israelis whose father had been born in Europe or 
America was found to be as high or higher than that found in immigrants from Europe or 
America.  Furthermore, the incidence of multiple sclerosis in native-born Israelis of 
European or American descent was significantly higher than the rate in native-born 
Israelis of African or Asian descent.  Once again, these data stress the genetic facets of 
the disease and suggest that being of African or Asian descent may present a preventative 
effect against developing multiple sclerosis (Kahana et al. 1994). 
 Other prevalence rates in the Middle East are fairly low.  Iraq exhibited a 
prevalence of 4, Saudi Arabia reported 10 cases per 100,000 at risk, Jordan reported 7 
cases, and Kuwait reported 24 cases per 100,000 (Rosati 2001).  The prevalence data 
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 Figure 3.  Frequency of multiple sclerosis in European  
 Russia.  Nat = prevalence in regional Natives (Rosati 2001). 
reported to MSIF by these countries were 6, 25, 7, and 10, respectively.  One possible 
explanation for the increased prevalence rates in Saudi Arabia and Kuwait could be that 
since these are two of the largest oil exporters in the world, they have been influenced by 
European and American migrants who have passed a genetic susceptibility to multiple 
sclerosis to the original inhabitants in these regions.   
   
Russian, Indian, and Asian multiple sclerosis prevalence and migration history of the 
northern Europeans. 
 As previously mentioned, Scandinavian migration primarily followed a south and 
westward route.  Scandinavians did not travel inland toward Russia and Asia where 
multiple sclerosis prevalence and incidence rates are relatively low (Wikipedia 2007b).    
European Russia and 
nations bordering 
Russia on the western 
side have reported 
multiple sclerosis 
prevalence rates 
ranging from 16 in 
Armenia to 50 in Latvia 
(MSIF 2006).  
Interestingly, in each 
of the nations in this 
region reported in Rosati’s review (2001), the multiple sclerosis prevalence recorded for 
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natives was much lower than for Russians in the respective country (Figure 3).  Rosati 
(2001) explained that the differences in these data imply that genetic factors related to 
development of the disease are very important.  It was also pointed out that the risk of 
multiple sclerosis among Russians born or living in the south portion of the former Soviet 
Union was lower than that among Russians in the mother-country.  This observation, 
Rosati (2001) explained, confirms a complementary role of environmental factors 
determining the geographic distribution of the disease.   
 Multiple sclerosis is considered to be a rare disease in India, China, Taiwan, and 
Japan.  Most of India did not report high levels multiple sclerosis prevalence.  It has been 
reported that although cases of multiple sclerosis have been recorded throughout India, 
the northern region of India suffers from higher prevalence of the disease than the 
southern portion.  Moreover, northern India was settled by Indo-Europeans, while the 
south part was settled by Tamil and Dravidian populations (Jain 1985).  To date, Poona 
and Bombay are the only regions of India with firmly reported incidence and prevalence 
rates.  Rosati (2001) reported that prevalence rates in Poona and Bombay were 58 and 28 
per 100,000 population at risk, respectively.  However, Singhal and Wadia (Bharucha 
1988) reported that multiple sclerosis prevalence was only 1 per 100,000 among native 
Indians in Bombay.  The Parsi ethnic group in Bombay and Poona was the population 
that exhibited the greater prevalence levels of the disease.  According to (Wadia 1990), 
the Parsis are of Persian origin and migrated to India in the 17th century.  It is possible 
that before their migration, Scandinavians had migrated to Persian regions and passed 
their susceptibility to multiple sclerosis to the Parsis.  
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 In China, the prevalence of multiple sclerosis is very low.  There are few studies 
from China and Taiwan on the epidemiology of multiple sclerosis, but of the ones that do 
exist, the disease appears to be very rare.  In 1986, a door-to-door study was conducted in 
Lang Cang Lu Hu Zu county of the Chinese Yunnan province, and it was estimated that 
the prevalence of the disease was 2 cases per 100,000 population at risk (Hung 1982).  In 
Taiwan and Hong Kong, studies indicate that the rate is 1 per 100,000 (Hung 1982, Yu 
1989, and Hou 1992).   
 Furthermore, multiple studies in Japan have indicated that the risk of developing 
multiple sclerosis in native Japanese is between 2 and 4 cases per 100,000 population at 
risk.  However, it should be noted that there is a higher prevalence of the disease in 
Japanese Americans.  Japanese Americans in Hawaii exhibited an elevated prevalence of 
9 cases per 100,000 population at risk (Alter 1971).   
 As previously noted, the Scandinavians did not travel inland to Russia, China, or 
India as frequently as they traveled by sea (Wikipedia 2007b and d).  Interestingly, the 
highest prevalence of multiple sclerosis in these regions has been reported in the western 
European nations bordering Russia as well as the northern and western regions of Italy 
bordering the Indian Ocean where Scandinavians did travel, albeit infrequently.  Again, 
these observations support the idea that a genetic susceptibility was passed from 
Scandinavians to other ethnic groups via genetic admixture between the groups at some 
point throughout history.   
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Native American, First Nations Canadian, Aboriginal Australian, and New Zealand 
Maori multiple sclerosis prevalence rates and migration history of the northern 
Europeans. 
Current explanations for the apparent ethnic disparity in multiple sclerosis and 
prevalence among native and aboriginal groups in Australia, North America and New 
Zealand include differences in socioeconomic factors and differences in environmental 
factors.   For instance, the Alaskan Inuit and New Zealand Maori are less likely to present 
with multiple sclerosis symptoms to medical practitioners since they often do not seek 
professional medical attention (Chan 1977, Miller 1986, and Acers 1994).  Also, these 
groups of people might be less likely to live in areas with exposure to environmental 
triggers of multiple sclerosis.  Australian aboriginals, for example, live close to the 
equator, and according to the environmental geographic theory regarding development of 
multiple sclerosis, would be unlikely to develop the disease.  However, yet another 
plausible explanation is that differential susceptibility to multiple sclerosis between these 
native groups and European groups is partially conferred by variation in genetic 
inheritance (Miller 1986).  
Multiple sclerosis prevalence is relatively low in Australia compared to northern 
European nations.  Rates from 11 in Northern Queensland, which is close to the equator, 
to 33 in Adelaide, which is in southern Australia, have been reported (Compston 1998).  
Interestingly, the British Royal Navy settled Australia’s eastern coast in the late 1700s 
(Wikipedia 2007a).  Moreover, they settled in the southern Australia region, which is 
now the capital, Sydney, and this is the region of Australia which currently exhibits the 
highest prevalence and incidence of multiple sclerosis.  Additionally, New Zealand was 
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first visited by British Captain James Cook in 1779, and the island, along with Tasmania, 
was settled in the 18th century by people from Great Britain, who had Scandinavian 
ancestry (Wikipedia 2007a).  New Zealand currently exhibits a multiple sclerosis 
prevalence of 69 cases per 100,000 population at risk (Compston 1998, Skegg 1987).  
Furthermore, there appears to be a gradient of distribution of multiple sclerosis in New 
Zealand, with higher prevalence rates exhibited in the south, and lower prevalence rates 
in the north.  This gradient has previously been correlated to the higher proportion of 
people of Scottish ancestry in the south (Skegg 1987), thus implicating that genetic 
susceptibility to the disease has been passed to inhabitants in southern New Zealand 
throughout history.   
Despite the relatively high prevalence rates exhibited by people of northern 
European ancestry in Australia, New Zealand, and North America, multiple sclerosis is 
considered to be a rare disease in aboriginal Australians, the Maoris in New Zealand, and 
the Native Americans in North America.  Warren et al. (2007) analyzed data from 
government health databases and described the incidence of multiple sclerosis among 
First Nations aboriginal people in the province of Alberta, Canada.  The researchers then 
compared the incidence in this group to the general population from 1994 to 2002.  It was 
found that the general population rates were consistently higher than First Nations rates, 
and prevalence was essentially stable over the same period of time.  First Nations people 
exhibited an incidence of 7.6 per 100,000, while the incidence of multiple sclerosis was 
20.6 per 100,000 for Canadians of northern European descent in 2002.  From 2000-2002 
for First Nations the incidence was 12.7 for females and 7.6 for males, with a female-to-
male ratio of 1.7:1.  In addition, during the same time period, the incidence of multiple 
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sclerosis in the general population of Alberta, Canada was 32.2 for females and 12.7 for 
males, with a female-to-male ratio of 2.5:1.  The high incidence rates are consistent with 
high prevalence rates reported for both groups in 2002: 99.9 per 100,000 for First Nations 
and 335.0 per 100,000 for the general population (Warren 2007).  Warren et al. (2007) 
found that the incidence of multiple sclerosis was, indeed, significantly lower in First 
Nations people than in the general population of Alberta; however, it was also found that 
the incidence rates in First Nations people would not be considered “rare” by worldwide 
standards (Warren et al. 2007). 
Furthermore, according to previous research studies, the incidence and prevalence 
of multiple sclerosis in the New Zealand Maori, a group of aboriginal people in New 
Zealand, have been reported to be substantially lower than in the European population. 
(Chancellor et al. 2003; Fawcett and Skegg 1988; Hornabrook 1971; and Miller et al.  
1986).  Remarkably, it has also been found that Caucasian individuals living in New 
Zealand who have Maori ancestry, appear to exhibit lower susceptibility to the disease 
(Skegg 1987). 
Finally, according to the National Multiple Sclerosis Society, multiple sclerosis is 
virtually nonexistent in Inuits (Chan 1977, Acers 1994, Poser 1994, and National 
Multiple Sclerosis Society 2007).  It has previously been hypothesized that these groups 
do not develop multiple sclerosis due to their diet of primarily animal meat and fish 
(Chan 1977).    However, this idea completely contradicts the popular belief that diets 
low in saturated fat with no red meat and no high fat dairy products are the diets that 
prevent development of multiple sclerosis as reported previously in the review of 
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literature (Esparza 1995, Ghadirian 1998, Munger 2000, and Schwarz and Leweling 
2005).  
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Table 2.  Global occurrence of multiple sclerosis listed from greatest to least 
prevalence  (Data obtained from MSIF 2006 unless noted with an asterisk.) 
Country Occurrence 
of MS per 
100,000 
Country Occurrence of 
MS per 
100,000 
**Scotland 187 Turkey 34 
Germany 149 Georgia 33 
United States of America 135 Yugoslavia 32 
Norway 132 South Africa 32 
Czech Republic 130 Romania 31 
Denmark 122 Barbados 26.3 
Poland 120 United Arab Emirates 26 
**Sweden 112 Malta 25 
Switzerland 110 **Saudi Arabia 25 
United Kingdom 110 Uruguay 22 
Iceland 110 Turkmenistan 20 
Finland 100 Brazil 18 
Netherlands 100 Argentina 18 
Ireland 100 Slovakia 17.5 
Luxembourg 100 **Macedonia 16 
Austria 100 Armenia 16 
Canada 100 Tunisia 15 
Italy 90 **Martinique 14 
Belgium 88 Bahrain 13 
Croatia 87.5 Chile 11.7 
New Zealand 85 **Kyrgyzstan 11 
**Slovenia 83 **Uzbekistan 11 
France 80 **Albania 10 
Bosnia and Herzegovina 80 Cuba 10 
Hungary 79 **Kuwait 10 
Greece 78 Mexico 9 
Australia 78 Libyan Arab Jamahiriya 9 
**Tasmania 68 Japan 8 
Spain 59 **Jordan 7 
Latvia 50 Iraq 6 
Portugal 50 Paraguay 5.7 
Serbia & Montenegro 50 Colombia 5 
**Israel 50 Costa Rica 4.25 
Belarus 47 Peru 4 
Bulgaria 44.5 India 3 
Cyprus 43 Guatemala 2.5 
Russian Federation 40 China 2 
Estonia 39 Viet Nam 2 
Lithuania 36 
 
Hong Kong 0.77 
** Data obtained from Rosati et al. 2001
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Figure 4.  Occurrence of multiple sclerosis in Europe and Eastern Europe, including Russia 
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Figure 5.  Occurrence of multiple sclerosis in the Middle East, the Far East, New Zealand, and Australia 
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Figure 6.  Occurrence of multiple sclerosis in North America, South America, and the Caribbean  
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Figure 7.  Global occurrence of multiple sclerosis and migration routes of Northern Europeans, Iberians, and Africans 
60 
Figure 8.  Occurrence of multiple sclerosis in Europe and Germanic, Viking, and Crusade migration route
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CHAPTER V 
DISCUSSION AND CONCLUSION 
 
The goal of this project was to give new insight regarding the etiology of multiple 
sclerosis.  Several theories regarding the etiology of the disease have been reviewed, 
including a geographic theory, a nutritional theory, and a genetic theory.  Although the 
geographic and nutritional theories have been thoroughly investigated by researchers, 
neither of them provides a conclusive explanation for the etiology of the disease, and 
there are discrepancies with respect to both theories. 
It has been suggested that nutrition and diet, particularly high consumption of 
animal fat and low intake of fish products, may play a role in the etiology of multiple 
sclerosis.  Judging from the literature review, this theory regarding the etiology of the 
disease is ambiguous and inconclusive.  There are contradictory findings regarding this 
theory.  Results suggesting that diets high in fat intake and consisting of red meat 
increase the risk of developing multiple sclerosis are easily contradicted when we look at 
the distribution of the disease.  For instance, the Inuits’ diet of almost entirely red meat 
and few vegetables does not coincide with evidence suggesting this is a risky diet 
considering that multiple sclerosis is virtually non-existent within this population (Chan 
1977 and Poser 1994).   
Furthermore, the geographic, or latitudinal theory, which states that as the 
distance from the equator increases, so does the incidence and prevalence of multiple 
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 sclerosis, was discounted with the examination of multiple sclerosis incidence in Sassari, 
Sardinia.    Researchers found that the incidence of multiple sclerosis in Sassari was 
much higher to be expected if the latitudinal theory fully explained the distribution of the 
disease when they compared local data with surrounding incidence levels in Europe and 
Italy (Rosati 2001). 
 Additionally, the latitudinal theory is contradicted by evidence showing that 
Native Americans, who live in the same latitudinal geographic area as northwestern 
United States residents, do not exhibit the same high prevalence of multiple sclerosis as 
the latter group (Multiple Sclerosis Research Group 1998, Warren et al. 2006).  This 
trend can be seen in almost any nation where northern Europeans have traveled and 
settled among natives of the respective region.  Furthermore, Kurtzke (1977) 
demonstrated that latitude is not a sufficient criterion for determining multiple sclerosis 
risk.  It was shown that at 40 degrees north latitude, multiple sclerosis is high in America, 
medium in Europe, and low in Asia.  This observation is completely inconsistent with the 
theory that multiple sclerosis incidence and prevalence increase as does distance from the 
equator increase.  It was, however, noted that high and medium risk areas appeared only 
in Europe or European colonies.   
Since multiple sclerosis occurs frequently in certain racial and ethnic groups, and 
since most nations of the world consist of a single ethnic group as population majority, a 
comparison of multiple sclerosis prevalence rates among nations should help to 
determine whether high prevalence of the disease concurs with migration, settlement, and 
admixture of an ethnic group that may carry certain susceptibility alleles.  Under this 
premise, the current project examined the geographic distribution of prevalence of 
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 multiple sclerosis and found that susceptibility to the disease is closely associated with 
the migration and settlement history of northern Europeans.  The gradient of disease 
prevalence which is demonstrated in Figure 2 results from the admixture of Scandinavian 
genes with ethnic groups in other parts of Europe throughout history.  Following 
admixture of the Scandinavian genome, susceptibility to multiple sclerosis was 
transmitted to other races and ethnic groups throughout the migration and settlement 
history of the Europeans by interracial admixture.  The current thesis research indicates 
that there is, indeed, a genetic susceptibility to multiple sclerosis which originated in 
Scandinavia, and the susceptibility alleles have been transmitted to other races by gene 
flow.  
Mendelian diseases exhibit distinct inheritance patterns when passed from one 
generation to another.  They are usually easily identified by a specific gene that 
segregates cleanly with the disease in affected families.  Multiple sclerosis has not been 
identified as a disease with clean Mendelian pedigree, and to date, no one gene has been 
determined to be the cause of multiple sclerosis.  Since multiple sclerosis cannot be fully 
described by a Mendelian genetic inheritance, a variety of genetic studies have been 
conducted to determine the genetic factors associated with the disease.  To date, more 
than 55 full and partial genome screens and follow-up studies have been conducted for 
multiple sclerosis, and hundreds of genetic markers have been examined in these studies 
producing a number of interesting loci related to the disease.  However, none of these loci 
have been shown to exhibit a particularly strong effect.   
 These data suggest that although there is not a particular Mendelian effect as far 
as genetics are concerned, it is likely that multiple sclerosis is a multi-gene disease and 
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 that it is a disease with etiologic alleles of low penetrance.  The low penetrance of a 
genotype would lead to an age-dependent and rare presentation of the corresponding trait, 
making it difficult to distinguish the genotype from external influences.  Conversely, 
Mendelian inheritance makes the trait unique in certain ethnic groups, which may be 
transmitted to other groups by admixture.  Since the genotype may have not yet been 
equally spread among different races and ethnic groups, the corresponding trait should be 
traceable, based on the migration, settlement, and admixture history of the original carrier.   
In addition, histories of both paternal and maternal relatives have similar. 
predicting power, indicating an autosomal transmission of susceptibility (Schaid et al. 
1998 and Valeri et al. 2003).  Multiple sclerosis is prevalent among Europeans, 
Americans of northern European descent, and African Americans, whereas it appears to 
be a rare occurrence in Asia and Africa (Rosati 2001).  The racial disparity is best 
explained by inheritance.  Lastly, a candidate locus for multiple sclerosis susceptibility 
has recently been found in patients in the European, European American, and African 
American populations (Reich et al. 2005).  In this case, it is clear that these unique 
genetic markers were transmitted by admixture between the two archeologically and 
anthropologically distinctive racial groups.  Theoretically, these facts demonstrate that 
multiple sclerosis is an inherited disease. 
 Presently, there is minimal research regarding the significance of interracial 
admixture as it relates to passing susceptibility alleles from one racial group to another.  
However, it is well understood that genetic susceptibility to a specific disease will be 
transmitted among groups when the groups in question are geographically adjacent to one 
another.  Susceptibility to cystic fibrosis, prostate cancer, and hemochromatosis are all 
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 diseases that have been linked to northern European origination (Higgins et al. 2005, 
Gilbert et al. 1995, and Sandblom et al. 2003).  It has been found that the susceptibility 
alleles of each of these diseases exist in racial and ethnic groups other than Caucasian 
northern Europeans.  The transmission of these alleles was due to inter-group admixture 
(Higgins et al. 2005, Gilbert et al. 1995, and Sandblom et al. 2003).   
Although the association between multiple sclerosis susceptibility and the 
migration history of the Europeans has been previously reported, the key conclusion of 
this study is that the high susceptibility in other racial and ethnic groups is due to 
admixture with Europeans.  There are few studies on the significance of interracial 
admixture with respect to the spreading of genetic susceptibilities, but previous research 
supports the idea that a genetic susceptibility will be transmitted from one group to 
another as long as these groups are geographically adjacent to one another.  For instance, 
northern Europeans are uniquely predisposed to diseases such as cystic fibrosis and 
idiopathic hemochromatosis.  The respective northern European alleles are found in other 
racial and ethnic groups due to inter-group admixture (Higgins et al. 2005, Gilbert et al. 
1995, Sandblom et al. 2003, Parra et al. 1998, Rybicki et al. 2002, Cabello et al. 1999, 
and Acton 2001). 
The geographic distribution of the ∆F508 cystic fibrosis allele is a typical 
example of the results of European admixture.  The mutation for cystic fibrosis originated 
in northwestern Europe, and it has been observed that the gradient distribution of its 
frequency in Europe is similar to that of multiple sclerosis prevalence.  Furthermore, the 
∆F508 allele has been transmitted to African Americans and Latin Americans through 
admixture in other parts of the world.  The similarity in their geographic distributions 
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 strongly suggests that, similar to cystic fibrosis, multiple sclerosis is transmitted by 
susceptibility alleles. 
Additionally, in the case of insulin-dependent diabetes mellitus (IDDM), genetic 
epidemiology has indicated that gene flow from Europeans is responsible for the 
increased frequency and the early onset of IDDM among young African Americans  
(Pereira et al. 2001 and Vizzi et al. 2005).  In addition, a recent genome linkage scan 
investigation defined two alleles at chromosome 8q24 that are associated with an 
increased prostate cancer incidence both in Northern Europeans and in African 
Americans, and the alleles seem to be of European ancestry (Pakkanen et al. 2007, 
Freedman et al. 2006, and Amundadottir et al. 2006).  These alleles are not frequently 
found in native Africans and other racial and ethnic groups.  It appears that these alleles 
are located in the chromosomes of northern Europeans, and that African American 
prostate cancer patients have inherited them through admixture with Europeans.  
The results of this project demonstrate an alternative approach to the 
identification of the susceptibility alleles.  Considering that admixture may transmit 
chromosomes from one race to another, probably in a random fashion, multiple sclerosis 
patients of non-European origin should share common European chromosomal 
components that harbor the susceptibility alleles (Reich et al. 2005).  These same 
components should be found in multiple sclerosis patients in Africa and Asia, and the 
indigenous peoples in America, Australia, and New Zealand.  Reich and colleagues 
(2005) noted that the tendency for multiple sclerosis to affect Europeans more frequently 
than Africans provided the opportunity to search for susceptibility genes by conducting 
an admixture linkage analysis.  They hypothesized that African-American individuals 
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 with multiple sclerosis would be expected to have a disproportionately greater degree of 
European ancestry in those regions of the genome encoding multiple sclerosis 
susceptibility genes, and they were able to implicate a novel susceptibility locus on 
chromosome 1.  The fact that linkage in this region among European families is 
nonexistent suggests that the responsible variant is likely to have a very high background 
frequency in Europeans.   This novel finding appears to explain the long-established 
excess risk seen in the European population and urgently requires replication and 
refinement (Reich et al. 2005). 
Defining the minimal European chromosomal components shared among multiple 
sclerosis patients could be an effective approach to a comprehensive isolation of the 
susceptibility alleles for the disease.  Determining and detecting the minimal European 
chromosomal components may be an accurate and reliable method for predicting the risk 
for developing multiple sclerosis at birth or early in life.  It is possible that with early 
detection of these chromosome components, multiple sclerosis could be prevented, since 
the susceptibility alleles may have low penetrance, and because the onset of the disease 
occurs primarily in later life. 
The results of this analysis may help to study other diseases that display 
substantial racial and ethnic differences in incidence.  It is known that, compared to other 
races and ethnicities, Europeans are more susceptible to multiple forms of malignancies 
(Weinstein et al. 2002).  Some of these malignancies, including breast cancer, lung 
cancer, and brain tumors, are known to be associated with genetic factors (Ahlbom et al. 
1997).  A study similar to the current one has been conducted with respect to prostate 
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 cancer.  Likewise, studies investigating the correlation between Scandinavian migration 
and settlement history and cancer incidence could be conducted.   
Currently, the etiology of multiple sclerosis is unknown.  Although inheritance 
primarily plays the determining role of whether an individual will develop the disease, 
other risk factors may have an immense effect on development.  The current project 
adapted a reductionistic approach to address the importance of inheritance, in isolation 
from other contributing factors.  The congruous geographic distribution between the 
European migration and settlement history and global multiple sclerosis prevalence is 
unlikely to be a coincidence.  Identification of the minimal European chromosome 
components shared in multiple sclerosis patients in other racial and ethnic groups should 
confirm the results of this analysis. 
A novel strategy to identify the etiology of multiple sclerosis was used in this 
study.  The international prevalence data for multiple sclerosis in respect to racial and 
ethnic constituents of nations worldwide, together with the global migratory history of 
racial and ethnical groups was examined, and this study revealed a previously 
unrecognized aspect of multiple sclerosis epidemiology: high prevalence of multiple 
sclerosis in certain regions is associated with migration and settlement history of certain 
human races.  This finding suggests that there is an inherited susceptibility to multiple 
sclerosis, which has been transmitted by admixture to different racial and ethnic groups. 
 
 
Limitations of this analysis 
 There were several major limitations to this research project.  First, the tabulated 
data from MSIF and literature sources were incomplete.  Data were collected from a 
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 variety of sources, but none of these sources had data from each country and some of the 
data were outdated, meaning the data were greater than 10 years old.  The most common 
reason for missing data is that it simply did not exist within the countries in question, 
specifically in African nations.  Second, the data used in this project were obtained from 
secondary sources.  All data were obtained from publications and websites dedicated to 
researching the epidemiology and etiology of diseases such as multiple sclerosis.  Some 
of these data sources had differing incidence and prevalence rates for the same country.  
In such cases, registry data were used over sample data, or the more reliable of the two 
rates was used (see Methods and Procedures).  Third, much of the data used in the current 
project were obtained from the Multiple Sclerosis International Federation, which 
collected data primarily from voluntary sector sources.  The Federation stated that a 
limitation to its own data collection methodology was that information regarding the 
public and private sectors may have been incomplete and may not have been completely 
generalizable or representative of the actual figures for the country in question. 
 Furthermore, both incidence and prevalence data were used in this analysis since 
prevalence data were not available for every country.  Out of the 77 countries examined, 
prevalence data were used in 64 of them, with few prevalence rates accordingly noted.  
Using both incidence and prevalence data could have possibly skewed the results of this 
analysis.  In future studies, it would be best to use only incidence or only prevalence data 
for each nation so that a baseline rate can be established. 
To resolve some of these limitations, it would be helpful for just one foundation, 
perhaps the MSIF or National Multiple Sclerosis Society to take responsibility for 
keeping an updated, cohesive record of global multiple sclerosis incidence and 
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 prevalence rates.  If one foundation could take responsibility for keeping the record up to 
date and accurate, it would resolve the issues of figure differences between groups and 
outdated information.  It would also be helpful to establish a registry of multiple sclerosis 
cases in Africa, where there currently is no such registry and thus prevalence data for the 
disease are difficult to find.   
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